Publications

Debska-Vielhaber G; Borucki K; Guest PC; Dudeck L; Bode-Böger S; Martens-Lobenhoffer J; Vielhaber S; Jerzykiewicz B; Dobrowolny H; Meyer-Lotz G; Steiner J. Peripheral immune-cell bioenergetics in acute and stable schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2026.

Rösch SA; Thiele C; Reinstaller T; Zähle T; Schag K; Giel K; Plewnia C; Steiner J; Junne F; Vogt S. Publisher Correction: Enhancing Postoperative Outcomes After Metabolic Bariatric Surgery: a Pilot Study of Inhibitory Control Training, Transcranial Direct Current Stimulation and Psychosocial Aftercare. Obes Surg. 2026;36(9):5025–5026.

Klein HC; Guest PC; Benros ME; Tunvirachaisakul C; Scheiber C; Maes M; Yolken R; Bechter K; Steiner J. CD163+ perivascular macrophages in schizophrenia: a research framework for testing macrophage-related mechanisms. Front Psychiatry. 2026;17:1833449.

Rösch SA; Thiele C; Reinstaller T; Zähle T; Schag K; Giel K; Plewnia C; Steiner J; Junne F; Vogt S. Enhancing Postoperative Outcomes After Metabolic Bariatric Surgery: a Pilot Study of Inhibitory Control Training, Transcranial Direct Current Stimulation and Psychosocial Aftercare. Obes Surg. 2026;36(8):4316–4327.

Dudeck L; Guest PC; Steiner J. From peripheral blood neutrophils and monocytes to microglia in the brain: Converging evidence for innate immune activation in schizophrenia and major depression. Dusunen Adam. 2026;39(2):75–79.

Guest PC; Cunningham JL; Raabe F; Schiltz K; Asl LS; Nickl-Jockschat T; Steiner J. From case-control averages to validated subgroups: Interpreting inflammatory and neuroaxonal-injury biomarkers in schizophrenia and major depression. Brain Behav Immun Health. 2026;55:101285.

Stein G; Müller P; Vallet M; Cirri E; Lange L; Heller E; Winter J; Gräler MH; Ueberschaar N; Maurer A; Dobrowolny H; Meyer-Lotz G; Steiner J; Engmann O. Systemic stress states are reversed by NPBWR1 inhibition. bioRxiv. 2026:2026.05.06.722954.

Nussbaumer M; Guest PC; Schiltz K; Dudeck L; Asl LS; Meyer-Lotz G; Dobrowolny H; Leucht S; Bernstein HG; Nickl-Jockschat T; Fernandes BS; Steiner J. Multimodal microglial and kynurenine pathway alterations across the affective-psychosis spectrum: a systematic review of patterns, heterogeneity, and dimensional implications. Mol Psychiatry. 2026;31(9):5242–5264.

Popovic D; Weyer C; Dwyer DB; Griffiths SL; Lalousis PA; Barnes NM; Vetter C; Neuner LM; Buciuman MO; Sarisik E; Paolini M; Lichtenstein T; Kambeitz-Ilankovic L; Kambeitz J; Ruhrmann S; Chisholm K; Schultze-Lutter F; Falkai P; Schiltz K; Steiner J; Ziller M; Pergola G; Blasi G; Bertolino A; Romer G; Lencer R; Dannlowski U; Salokangas RKR; Pantelis C; Brambilla P; Borgwardt S; Wood SJ; Meisenzahl E; Koutsouleris N; Upthegrove R; PRONIA Consortium. Multivariate Brain-Blood Signatures in Early-Stage Depression and Psychosis. JAMA Psychiatry. 2026;83(2):172–184.

von Gilsa A; Steiner J; Gos A; Trübner K; Mawrin C; Kaliszan M; Nickl-Jockschat T; Gos T. Impairment of the GABAergic system in the prefrontal cortex of male heroin addicts. Eur Arch Psychiatry Clin Neurosci. 2026;276(1):339–348.

Dudeck L; Nussbaumer M; Nickl-Jockschat T; Guest PC; Dobrowolny H; Meyer-Lotz G; Zhao Z; Jacobs R; Schiltz K; Fernandes BS; Steiner J. Differences in Blood Leukocyte Subpopulations in Schizophrenia: A Systematic Review and Meta-Analysis. JAMA Psychiatry. 2025;82(5):492–504.

Finlay S.; Suvarna B.; Adegboye O.; Rudd D.; McDermott B.; Westphal S.; Guest P.C.; Meyer-Lotz G.; Dobrowolny H.; Bahn S.; Steiner J.; Sarnyai Z. Allostatic load in major depressive disorder: An in-patient clinical study. Psychoneuroendocrinology. 2025;182:107653.

Mukherjee K.; Guest P.C.; Nussbaumer M.; Dudeck L.; Shokati Asl L.; Meyer-Lotz G.; Dobrowolny H.; Borucki K.; Bernstein H.-G.; Link A.; Relja B.; Schiltz K.; Nickl-Jockschat T.; Steiner J. Assessment of intestinal barrier integrity and associations with innate immune activation and metabolic syndrome in acutely ill, antipsychotic-free schizophrenia patients. Journal of Neuroinflammation. 2025;22(1):232.

Seidenbecher S.; Kaufmann J.; Schöne M.; Dobrowolny H.; Schiltz K.; Frodl T.; Steiner J.; Bogerts B.; Nickl-Jockschat T. Association between white matter microstructural changes and aggressiveness. A case-control diffusion tensor imaging study. NeuroImage: Clinical. 2025;45:103712.

Andreazza A.C.; Barros L.F.; Behnke A.; Ben-Shachar D.; Berretta S.; Chouinard V.-A.; Do K.; Edwin Thanarajah S.; Ehrenreich H.; Falkai P.; Ford J.; Freyberg Z.; Gilbert-Jaramillo J.; Glausier J.R.; Goyal M.S.; Hahn M.; Herculano-Houzel S.; Hofmann D.; Kolassa I.-T.; Mack M.; Mavioglu R.N.; McCullumsmith R.; Milaneschi Y.; Molina A.J.A.; Mujica-Parodi L.; Öngür D.; Paulus M.; Peleg-Raibstein D.; Perry B.; Picard M.; Pillinger T.; Rae C.; Rothman D.; Sarnyai Z.; Steiner J.; Upthegrove R.; Vernon A.C.; Wall M.; Weistuch C. Brain and body energy metabolism and potential for treatment of psychiatric disorders. Nature Mental Health. 2025;3(7):763–771.

Bernstein H.-G.; Nussbaumer M.; Vasilevska V.; Dobrowolny H.; Nickl-Jockschat T.; Guest P.C.; Steiner J. Glial cell deficits are a key feature of schizophrenia: implications for neuronal circuit maintenance and histological differentiation from classical neurodegeneration. Molecular Psychiatry. 2025;30(3):1102–1116.

Gos A.; Steiner J.; Trübner K.; Mawrin C.; Kaliszan M.; Gos T. Impairment of the GABAergic system in the anterior insular cortex of heroin-addicted males. European Archives of Psychiatry and Clinical Neuroscience. 2025;275(1):219–226.

von Gilsa A.; Steiner J.; Gos A.; Trübner K.; Mawrin C.; Kaliszan M.; Nickl-Jockschat T.; Gos T. Impairment of the GABAergic system in the anterior midcingulate cortex of heroin-addicted males. European Archives of Psychiatry and Clinical Neuroscience. 2025;275(7):2111–2118.

Strischewski D.; Kalmar A.; Guest P.C.; Dobrowolny H.; Meyer-Lotz G.; Schiffner C.J.; Jordan W.; Müller U.J.; Borucki K.; Böttcher M.; Relja B.; Steiner J. Naturalistic comparison of clomethiazole and Diazepam treatment in alcohol withdrawal: effects on oxidative stress, inflammatory cytokines and hepatic biomarkers. European Archives of Psychiatry and Clinical Neuroscience. 2025;275(2):573–579.

Nickl-Jockschat T.; Steiner J.; Hirjak D.; Hasan A. Schizophrenia and catatonia: from ICD-10 to ICD-11. German version; [Schizophrenie und Katatonie: von der ICD-10 zur ICD-11]. Der Nervenarzt. 2025;96(7):640–647.

Nickl-Jockschat T.; Steiner J.; Hirjak D.; Hasan A. Schizophrenia and catatonia: from ICD-10 to ICD-11; [Schizophrenie und Katatonie: von der ICD-10 zur ICD-11. Englische Version]. Der Nervenarzt. 2025;96:11–16.

Tzartos J.; Karagiorgou K.; Pechlivanidou M.; Tzartos S.; Dudeck L.; Meyer-Lotz G.; Guest P.C.; Steiner J. Absence of neuronal nicotinic acetylcholine receptor antibodies in sera and CSF from schizophrenia patients. Schizophrenia Research. 2024;267:39–41.

Campana M.; Yakimov V.; Moussiopoulou J.; Maurus I.; Löhrs L.; Raabe F.; Jäger I.; Mortazavi M.; Benros M.E.; Jeppesen R.; Meyer zu Hörste G.; Heming M.; Giné-Servén E.; Labad J.; Boix E.; Lennox B.; Yeeles K.; Steiner J.; Meyer-Lotz G.; Dobrowolny H.; Malchow B.; Hansen N.; Falkai P.; Siafis S.; Leucht S.; Halstead S.; Warren N.; Siskind D.; Strube W.; Hasan A.; Wagner E. Association of symptom severity and cerebrospinal fluid alterations in recent onset psychosis in schizophrenia-spectrum disorders – An individual patient data meta-analysis. Brain, Behavior, and Immunity. 2024;119:353–362.

Allartz P.; Hotop S.-K.; Muntau B.; Schlaphof A.; Thomé-Bolduan C.; Gabriel M.; Petersen N.; Lintzel M.; Behrens C.; Eggert P.; Pörtner K.; Steiner J.; Brönstrup M.; Tappe D. Detection of bornavirus-reactive antibodies and BoDV-1 RNA only in encephalitis patients from virus endemic areas: a comparative serological and molecular sensitivity, specificity, predictive value, and disease duration correlation study. Infection. 2024;52(1):59–71.

Rösch S.A.; Wünsche L.; Thiele C.; Reinstaller T.; Zähle T.; Schag K.; Giel K.E.; Plewnia C.; Steiner J.; Junne F. Enhancing the outcomes of bariatric surgery with inhibitory control training, electrical brain stimulation and psychosocial aftercare: a pilot study protocol. Journal of Eating Disorders. 2024;12(1):202.

Schultze-Lutter F.; Banaschewski T.; Barth G.M.; Bechdolf A.; Bender S.; Flechtner H.-H.; Hackler S.; Heuer F.H.; Hohmann S.; Holzner L.; Huss M.; Koutsouleris N.; Lipp M.; Mandl S.; Meisenzahl E.; Munz M.; Osman N.; Peschl J.; Reissner V.; Renner T.; Riedel A.; Romanos M.; Romer G.; Schomerus G.; Thiemann U.; Uhlhaas P.J.; Woopen C.; Correll C.U.; Leyens S.B.U.; Meyhöfer I.; Neufang S.; Wege N.; Kujovic M.; Mollamehmetoglu D.; Theisen C.; Wrulich M.; Frings M.; Cabrera S.; Grund A.; Heindl P.; Neuner L.-M.; Plett C.; Ruef A.; Weyer C.; Eberle C.; Schulte-Körne G.; Schneider M.; Jessen F.; Kambeitz J.; Kambeitz-Ilankovic L.; Müller S.; Inanloo-Shavikloo S.; Synetou A.; Wenzel J.; Martin J.; Michel J.; Schwinde H.; Philipsen A.; Rohner H.; Wasserthal S.; van der Coelen C.; Daniels J.; Gladbach M.; Gesell D.; Bijlard N.; Dannlowski U.; Böthig A.; Goltermann J.; Grotegerd D.; Bonnekoh L.M.; Göder R.; Quant E.; Wiesner F.; Euent M.; Borgwardt S.; Heide M.; Eickhoff S.; Reiring P.; Franzen L.; Soyka O.; Kallmeyer M.; Johannsen M.; Deckert J.; Hütz B.; Zängler J.; Bakhtiari G.; Nieberler M.; Aster H.-C.; Geissler J.; Heinz A.; Schlagenhauf F.; Kaminski J.; Assadi Z.; Katthagen T.; Naujoks C.; Steiner J.; Incesoy E.I.; Strehlow A.; Weigand S.; Wiegel M.; Krämer R.; Krauel K.; Frodl T.; Neuner I.; Kesik J.; Ritters A.; Schnellbächer G.; Juckel G.; Daly V.-E.; Birner R.S.; Bori-Kovács E.; Lenders C.; Meister K.; Gabriel J.; Ghanam A.R.; Gramsch C.; Jedamzik T.; Hirjak D.; Palacio S.F.; Schwarz E.; Volkmer S.; Daub J.; Becker K.; Häge A.; Klos B.; Gerth C.; Feil N.; Eleftheriadis M.; Boettcher J.; Sammoum F.; Klingberg S.; Fallgatter A.J.; Unsöld S.; Rau A.; Krüger L.; Steinwand P.; Fausel J.; Müller E.; Mroß M.; Schäfer E.; Mier D.; Stumpp S.; Bley L.; Diedrich P.; Wolber A.; Herwig U.; Zoll M.; Senner S.; Gallinat J.; Lambert M.; Rohenkohl A.C.; Balzar A.; Sowada P.; Tlach L.; Schwedhelm J.; Mey M.; Bauer M.; Pfennig A.; Mennigen E.; Boehm I.; Bröckel-Bundt K.; Gliemann M.; Maicher B.; Berndt C.; Leopold K.; Genccagj D.; van Hardenberg L.; Kanlidere S.; Schumacher N.; Shmuilovich O.; Hasan A.; Greiner S.-K.; Riedlinger S.; Strasser A.M.; Strube W. Ethical Considerations of Including Minors in Clinical Trials Using the Example of the Indicated Prevention of Psychotic Disorders; [Minderjährige in klinischen Prüfungen: Ethische Abwägungen ihres Einbezugs am Beispiel der indizierten Prävention psychotischer Erkrankungen]. Zeitschrift fur Kinder- und Jugendpsychiatrie und Psychotherapie. 2024;52(5):261–289.

Dinges L.; Fiedler M.-A.; Al-Hamadi A.; Hempel T.; Abdelrahman A.; Weimann J.; Bershadskyy D.; Steiner J. Exploring facial cues: automated deception detection using artificial intelligence. Neural Computing and Applications. 2024;36(24):14857–14883.

Gos A.; Steiner J.; Trübner K.; Ungewickell J.; Mawrin C.; Karnecki K.; Kaliszan M.; Gos T. Inverse pattern of GABAergic system impairment in the external versus internal globus pallidus in male heroin addicts. European Archives of Psychiatry and Clinical Neuroscience. 2024;274(2):445–452.

Mukherjee K.; Guest P.C.; Schiltz K.; Meyer-Lotz G.; Dobrowolny H.; Borucki K.; Bernstein H.-G.; Nickl-Jockschat T.; Relja B.; Steiner J. Longitudinal analysis of astrocyte-derived protein levels in the blood of drug-naive and relapsed patients with schizophrenia. Journal of Psychiatric Research. 2024;180:301–306.

Pechlivanidou M.; Vakrakou A.G.; Karagiorgou K.; Tüzün E.; Karachaliou E.; Chroni E.; Afrantou T.; Grigoriadis N.; Argyropoulou C.; Paschalidis N.; Şanlı E.; Tsantila A.; Dandoulaki M.; Ninou E.I.; Zisimopoulou P.; Mantegazza R.; Andreetta F.; Dudeck L.; Steiner J.; Lindstrom J.M.; Tzanetakos D.; Voumvourakis K.; Giannopoulos S.; Tsivgoulis G.; Tzartos S.J.; Tzartos J. Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders. Frontiers in Immunology. 2024;15:1388998.

Vasilevska V.; Guest P.C.; Szardenings M.; Benros M.E.; Steiner J. Possible temporal relationship between SARS-CoV-2 infection and anti-NMDA receptor encephalitis: a meta-analysis. Translational Psychiatry. 2024;14(1):139.

Savukoski S.; Mannes M.; Wohlgemuth L.; Schultze A.; Guest P.C.; Meyer-Lotz G.; Dobrowolny H.; Relja B.; Huber-Lang M.; Steiner J. Soluble terminal complement complex blood levels are elevated in schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2024;274(5):1215–1222.

Guest P.C.; Neyazi A.; Braun-Dullaeus R.C.; Müller P.; Schreiber J.; Haghikia A.; Vasilevska V.; Steiner J. A Molecular Biomarker-Based Triage Approach for Targeted Treatment of Post-COVID-19 Syndrome Patients with Persistent Neurological or Neuropsychiatric Symptoms. Advances in Experimental Medicine and Biology. 2023;1412:97–115.

Pechlivanidou M.; Ninou E.; Karagiorgou K.; Tsantila A.; Mantegazza R.; Francesca A.; Furlan R.; Dudeck L.; Steiner J.; Tzartos J.; Tzartos S. Autoimmunity to neuronal nicotinic acetylcholine receptors. Pharmacological Research. 2023;192:106790.

Singh D.; Dobrowolny H.; Kapogiannis D.; Steiner J. Canonical insulin signaling is not significantly impaired in early stages of depression. European Archives of Psychiatry and Clinical Neuroscience. 2023;273(1):283–286.

Seidenbecher S.; Dobrowolny H.; Wolter S.; Klemen J.; Meyer-Lotz G.; Gescher D.M.; Steiner J.; Frodl T. Consequences of the Lockdown: Domestic Violence During the COVID-19 Pandemic. Advances in Experimental Medicine and Biology. 2023;1412:53–72.

Singh D.; Guest P.C.; Dobrowolny H.; Fischbach T.; Meyer-Lotz G.; Breitling-Ziegler C.; Haghikia A.; Vielhaber S.; Steiner J. Cytokine alterations in CSF and serum samples of patients with a first episode of schizophrenia: results and methodological considerations. European Archives of Psychiatry and Clinical Neuroscience. 2023;273(6):1387–1393.

Guest P.C.; Vasilevska V.; Al-Hamadi A.; Eder J.; Falkai P.; Steiner J. Digital technology and mental health during the COVID-19 pandemic: a narrative review with a focus on depression, anxiety, stress, and trauma. Frontiers in Psychiatry. 2023;14:1227426.

Guest P.C.; Borgwardt S.; Steiner J. Editorial: Back to the future: on the road towards precision psychiatry, volume II. Frontiers in Psychiatry. 2023;14:1355085.

Karnecki K.; Gos T.; Steiner J.; Mańkowski D.; Kaliszan M. Epidemiology of suicide in the Tri-City metropolitan area in Poland in 2010–2019. European Archives of Psychiatry and Clinical Neuroscience. 2023;273(4):911–920.

Klein H.C.; Guest P.C.; Dobrowolny H.; Steiner J. Inflammation and viral infection as disease modifiers in schizophrenia. Frontiers in Psychiatry. 2023;14:1231750.

Bonnekoh L.M.; Seidenbecher S.; Knigge K.; Hünecke A.-K.; Metzger C.D.; Tempelmann C.; Kanowski M.; Kaufmann J.; Meyer-Lotz G.; Schlaaff K.; Dobrowolny H.; Tozzi L.; Gescher D.M.; Steiner J.; Kirschbaum C.; Frodl T. Long-term cortisol stress response in depression and comorbid anxiety is linked with reduced N-acetylaspartate in the anterior cingulate cortex. World Journal of Biological Psychiatry. 2023;24(1):34–45.

Steiner J.; Schmitt A.; Falkai P. Publishing Negative Results of Neurobiological Studies in Mental Disorders Will Advance Knowledge in Pathophysiology. Schizophrenia Bulletin. 2023;49(3):539–541.

Müller U.J.; Schmalenbach L.J.; Dobrowolny H.; Guest P.C.; Schlaaff K.; Mawrin C.; Truebner K.; Bogerts B.; Gos T.; Bernstein H.-G.; Steiner J. Reduced anterior insular cortex volume in male heroin addicts: a postmortem study. European Archives of Psychiatry and Clinical Neuroscience. 2023;273(6):1233–1241.

Schmitz I.; da Silva A.; Bobermin L.D.; Gonçalves C.-A.; Steiner J.; Quincozes-Santos A. The Janus face of antipsychotics in glial cells: Focus on glioprotection. Experimental Biology and Medicine. 2023;248(22):2120–2130.

Karnecki K.; Świerczyński J.; Steiner J.; Krzyżanowska M.; Kaliszan M.; Gos T. The left-lateralisation of citrate synthase activity in the anterior cingulate cortex of male violent suicide victims. European Archives of Psychiatry and Clinical Neuroscience. 2023;273(6):1225–1232.

Bernstein H.-G.; Keilhoff G.; Dobrowolny H.; Steiner J. The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS - A critical overview. Reviews in the Neurosciences. 2023;34(1):1–24.

Bernstein H.-G.; Smalla K.-H.; Keilhoff G.; Dobrowolny H.; Kreutz M.R.; Steiner J. The many “Neurofaces” of Prohibitins 1 and 2: Crucial for the healthy brain, dysregulated in numerous brain disorders. Journal of Chemical Neuroanatomy. 2023;132:102321.

Krčmář L.; Jäger I.; Boudriot E.; Hanken K.; Gabriel V.; Melcher J.; Klimas N.; Dengl F.; Schmoelz S.; Pingen P.; Campana M.; Moussiopoulou J.; Yakimov V.; Ioannou G.; Wichert S.; DeJonge S.; Zill P.; Papazov B.; de Almeida V.; Galinski S.; Gabellini N.; Hasanaj G.; Mortazavi M.; Karali T.; Hisch A.; Kallweit M.S.; Meisinger V.J.; Löhrs L.; Neumeier K.; Behrens S.; Karch S.; Schworm B.; Kern C.; Priglinger S.; Malchow B.; Steiner J.; Hasan A.; Padberg F.; Pogarell O.; Falkai P.; Schmitt A.; Wagner E.; Keeser D.; Raabe F.J. The multimodal Munich Clinical Deep Phenotyping study to bridge the translational gap in severe mental illness treatment research. Frontiers in Psychiatry. 2023;14:1179811.

Schneider J.; Dobrowolny H.; Meyer-Lotz G.; Steiner J. White blood cell patterns differ in male patients with schizophrenia and depression due to cortisol awakening response. Journal of Psychiatric Research. 2023;160:177–179.

Franzka P.; Turecki G.; Cubillos S.; Kentache T.; Steiner J.; Walter M.; Hübner C.A.; Engmann O. Altered mannose metabolism in chronic stress and depression is rapidly reversed by vitamin B12. Frontiers in Nutrition. 2022;9:981511.

Guest P.C.; Popovic D.; Steiner J. Challenges of Multiplex Assays for COVID-19 Research: A Machine Learning Perspective. Methods in Molecular Biology. 2022;2511:37–50.

Singh D.; Guest P.C.; Dobrowolny H.; Vasilevska V.; Meyer-Lotz G.; Bernstein H.-G.; Borucki K.; Neyazi A.; Bogerts B.; Jacobs R.; Steiner J. Changes in leukocytes and CRP in different stages of major depression. Journal of Neuroinflammation. 2022;19(1):74.

Steiner J.; Dobrowolny H.; Guest P.C.; Bernstein H.-G.; Fuchs D.; Roeser J.; Summergrad P.; Oxenkrug G. Gender-specific elevation of plasma anthranilic acid in schizophrenia: Protection against glutamatergic hypofunction?. Schizophrenia Research. 2022;243:483–485.

Förster A.; Model V.; Gos T.; Frodl T.; Schiltz K.; Dobrowolny H.; Meyer-Lotz G.; Guest P.C.; Mawrin C.; Bernstein H.-G.; Bogerts B.; Schlaaff K.; Steiner J. Reduced GABAergic neuropil and interneuron profiles in schizophrenia: Complementary analysis of disease course-related differences. Journal of Psychiatric Research. 2022;145:50–59.

Gos T.; Steiner J.; Trübner K.; Krzyżanowska M.; Kaliszan M. Ribosomal DNA transcription is increased in the left nucleus accumbens of heroin-dependent males. European Archives of Psychiatry and Clinical Neuroscience. 2022;272(8):1603–1609.

Steiner J.; Stoecker W.; Teegen B.; Dobrowolny H.; Meyer-Lotz G.; Borucki K.; Guest P.C.; Bernstein H.-G. Testing for Thyroid Peroxidase and Antineuronal Antibodies in Depression and Schizophrenia. Methods in Molecular Biology. 2022;2343:203–213.

Brisch R.; Wojtylak S.; Saniotis A.; Steiner J.; Gos T.; Kumaratilake J.; Henneberg M.; Wolf R. The role of microglia in neuropsychiatric disorders and suicide. European Archives of Psychiatry and Clinical Neuroscience. 2022;272(6):929–945.

Jiang C.; Dobrowolny H.; Gescher D.M.; Meyer-Lotz G.; Steiner J.; Hoeschen C.; Frodl T. Volatile organic compounds from exhaled breath in schizophrenia. World Journal of Biological Psychiatry. 2022;23(10):773–784.

Krzyżanowska M.; Steiner J.; Gos T. AgNOR parameters of dorsal raphe nucleus neurons as a potential diagnostic tool which could aid the differentiation between suicidal and non-suicidal death. European Archives of Psychiatry and Clinical Neuroscience. 2021;271(3):587–589.

Karnecki K.; Steiner J.; Guest P.C.; Krzyżanowska M.; Mańkowski D.; Gos T.; Kaliszan M. Epidemiology of suicide in the Tricity metropolitan area in northern Poland 1980–2009: Evidence of influence by political and socioeconomic changes. Forensic Science International: Reports. 2021;3:100219.

Vasilevska V.; Guest P.C.; Bernstein H.-G.; Schroeter M.L.; Geis C.; Steiner J. Molecular mimicry of NMDA receptors may contribute to neuropsychiatric symptoms in severe COVID-19 cases. Journal of Neuroinflammation. 2021;18(1):245.

Steiner J.; Dobrowolny H.; Guest P.C.; Bernstein H.-G.; Fuchs D.; Roeser J.; Summergrad P.; Oxenkrug G.F. Plasma Anthranilic Acid and Leptin Levels Predict HAM-D Scores in Depressed Women. International Journal of Tryptophan Research. 2021;14.

Vasilevska V.; Guest P.C.; Schlaaff K.; Incesoy E.I.; Prüss H.; Steiner J. Potential Cross-Links of Inflammation With Schizophreniform and Affective Symptoms: A Review and Outlook on Autoimmune Encephalitis and COVID-19. Frontiers in Psychiatry. 2021;12:729868.

Müller U.J.; Ahrens M.; Vasilevska V.; Dobrowolny H.; Schiltz K.; Schlaaff K.; Mawrin C.; Frodl T.; Bogerts B.; Gos T.; Truebner K.; Bernstein H.-G.; Steiner J. Reduced habenular volumes and neuron numbers in male heroin addicts: a post-mortem study. European Archives of Psychiatry and Clinical Neuroscience. 2021;271(5):835–845.

Krzyżanowska M.; Rębała K.; Steiner J.; Kaliszan M.; Pieśniak D.; Karnecki K.; Wiergowski M.; Brisch R.; Braun K.; Jankowski Z.; Kosmowska M.; Chociej J.; Gos T. Reduced ribosomal DNA transcription in the prefrontal cortex of suicide victims: consistence of new molecular RT-qPCR findings with previous morphometric data from AgNOR-stained pyramidal neurons. European Archives of Psychiatry and Clinical Neuroscience. 2021;271(3):567–576.

Bernstein H.-G.; Keilhoff G.; Steiner J. The implications of hypothalamic abnormalities for schizophrenia. Handbook of Clinical Neurology. 2021;182:107–120.

Martins-de-Souza D.; Guest P.C.; Steiner J. A proteomic signature associated to atypical antipsychotic response in schizophrenia patients: a pilot study. European Archives of Psychiatry and Clinical Neuroscience. 2020;270(1):127–134.

Falkai P.; Raabe F.; Bogerts B.; Schneider-Axmann T.; Malchow B.; Tatsch L.; Huber V.; Slapakova L.; Dobrowolny H.; Schmitz C.; Cantuti-Castelvetri L.; Simons M.; Steiner J.; Schmitt A. Association between altered hippocampal oligodendrocyte number and neuronal circuit structures in schizophrenia: a postmortem analysis. European Archives of Psychiatry and Clinical Neuroscience. 2020;270(4):413–424.

Steiner J.; Schiltz K.; Stoecker W.; Teegen B.; Dobrowolny H.; Meyer-Lotz G.; Pennewitz M.; Borucki K.; Frodl T.; Bernstein H.-G. Association of thyroid peroxidase antibodies with anti-neuronal surface antibodies in health, depression and schizophrenia – Complementary linkage with somatic symptoms of major depression. Brain, Behavior, and Immunity. 2020;90:47–54.

Endres D.; Leypoldt F.; Bechter K.; Hasan A.; Steiner J.; Domschke K.; Wandinger K.-P.; Falkai P.; Arolt V.; Stich O.; Rauer S.; Prüss H.; van Elst L.T. Autoimmune encephalitis as a differential diagnosis of schizophreniform psychosis: clinical symptomatology, pathophysiology, diagnostic approach, and therapeutic considerations. European Archives of Psychiatry and Clinical Neuroscience. 2020;270(7):803–818.

Steiner J.; Prüss H.; Köhler S.; Frodl T.; Hasan A.; Falkai P. Autoimmune encephalitis with psychosis: Warning signs, step-by-step diagnostics and treatment. World Journal of Biological Psychiatry. 2020;21(4):241–254.

Pollak T.A.; Lennox B.R.; Müller S.; Benros M.E.; Prüss H.; Tebartz van Elst L.; Klein H.; Steiner J.; Frodl T.; Bogerts B.; Tian L.; Groc L.; Hasan A.; Baune B.T.; Endres D.; Haroon E.; Yolken R.; Benedetti F.; Halaris A.; Meyer J.H.; Stassen H.; Leboyer M.; Fuchs D.; Otto M.; Brown D.A.; Vincent A.; Najjar S.; Bechter K. Autoimmune psychosis: an international consensus on an approach to the diagnosis and management of psychosis of suspected autoimmune origin. The Lancet Psychiatry. 2020;7(1):93–108.

Bernstein H.-G.; Keilhoff G.; Dobrowolny H.; Steiner J. Binding varicella zoster virus: an underestimated facet of insulin-degrading enzyme´s implication for Alzheimer´s disease pathology?. European Archives of Psychiatry and Clinical Neuroscience. 2020;270(4):495–496.

Garcia-Rosa S.; Carvalho B.S.; Guest P.C.; Steiner J.; Martins-de-Souza D. Blood plasma proteomic modulation induced by olanzapine and risperidone in schizophrenia patients. Journal of Proteomics. 2020;224:103813.

de Almeida V.; Alexandrino G.L.; Aquino A.; Gomes A.F.; Murgu M.; Dobrowolny H.; Guest P.C.; Steiner J.; Martins-de-Souza D. Changes in the blood plasma lipidome associated with effective or poor response to atypical antipsychotic treatments in schizophrenia patients. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2020;101:109945.

Fernandes B.S.; Borgwardt S.; Carvalho A.F.; Steiner J. Editorial: Back to the Future: On the Road Towards Precision Psychiatry. Frontiers in Psychiatry. 2020;11:112.

Bernstein H.-G.; Keilhoff G.; Dobrowolny H.; Steiner J. Enhanced mitochondrial autophagy (mitophagy) in oligodendrocytes might play a role in white matter pathology in schizophrenia. Medical Hypotheses. 2020;134:109443.

Bernstein H.-G.; Keilhoff G.; Dobrowolny H.; Lendeckel U.; Steiner J. From putative brain tumor marker to high cognitive abilities: Emerging roles of a disintegrin and metalloprotease (ADAM) 12 in the brain. Journal of Chemical Neuroanatomy. 2020;109:101846.

Schlaaff K.; Dobrowolny H.; Frodl T.; Mawrin C.; Gos T.; Steiner J.; Bogerts B. Increased densities of T and B lymphocytes indicate neuroinflammation in subgroups of schizophrenia and mood disorder patients. Brain, Behavior, and Immunity. 2020;88:497–506.

Steiner J.; Frodl T.; Schiltz K.; Dobrowolny H.; Jacobs R.; Fernandes B.S.; Guest P.C.; Meyer-Lotz G.; Borucki K.; Bahn S.; Bogerts B.; Falkai P.; Bernstein H.-G. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment. Schizophrenia Bulletin. 2020;46(2):363–373.

Guest P.C.; Bernstein H.-G.; Dobrowolny H.; Borucki K.; Westphal S.; Steiner J. Measurement of a Surrogate Biomarker for Arginine Vasopressin Secretion in Association with Physiometric and Molecular Biomarkers of Aging. Methods in Molecular Biology. 2020;2138:251–262.

Bernstein H.-G.; Keilhoff G.; Dobrowolny H.; Guest P.C.; Steiner J. Perineuronal oligodendrocytes in health and disease: The journey so far. Reviews in the Neurosciences. 2020;31(1):89–99.

Steiner J.; Bernstein H.-G.; Guest P.C.; Summergrad P.; Oxenkrug G. Plasma leptin correlates with anthranilic acid in schizophrenia but not in major depressive disorder. European Neuropsychopharmacology. 2020;41:167–168.

Krzyżanowska M.; Steiner J.; Pieśniak D.; Karnecki K.; Kaliszan M.; Wiergowski M.; Rębała K.; Brisch R.; Braun K.; Jankowski Z.; Kosmowska M.; Chociej J.; Gos T. Ribosomal DNA transcription in prefrontal pyramidal neurons is decreased in suicide. European Archives of Psychiatry and Clinical Neuroscience. 2020;270(7):859–867.

Bernstein H.-G.; Keilhoff G.; Dobrowolny H.; Steiner J. SLC solute carrier transporters and neurodegenerative disorders: Drawing attention to cationic amino acid transporters 1 and 2. Clinical Psychopharmacology and Neuroscience. 2020;18(3):467–468.

Endres D.; Bechter K.; Prüss H.; Hasan A.; Steiner J.; Leypoldt F.; Tebartz van Elst L. Autoantibody-associated schizophreniform psychoses: clinical symptomatology; [Autoantikörper-assoziierte schizophreniforme Psychosen: klinische Symptomatik]. Nervenarzt. 2019;90(5):547–563.

Tebartz van Elst L.; Bechter K.; Prüss H.; Hasan A.; Steiner J.; Leypoldt F.; Endres D. Autoantibody-associated schizophreniform psychoses: pathophysiology, diagnostics, and treatment; [Autoantikörper-assoziierte schizophreniforme Psychosen: Pathophysiologie, Diagnostik und Therapie]. Nervenarzt. 2019;90(7):745–761.

Silva-Costa L.C.; Garcia-Rosa S.; Smith B.J.; Baldasso P.A.; Steiner J.; Martins-de-Souza D. Blood plasma high abundant protein depletion unintentionally carries over 100 proteins. Separation Science Plus. 2019;2(12):449–456.

Steiner J.; Fernandes B.S.; Guest P.C.; Dobrowolny H.; Meyer-Lotz G.; Westphal S.; Borucki K.; Schiltz K.; Sarnyai Z.; Bernstein H.-G. Glucose homeostasis in major depression and schizophrenia: a comparison among drug-naïve first-episode patients. European Archives of Psychiatry and Clinical Neuroscience. 2019;269(4):373–377.

Kapogiannis D.; Dobrowolny H.; Tran J.; Mustapic M.; Frodl T.; Meyer-Lotz G.; Schiltz K.; Schanze D.; Rietschel M.; Bernstein H.-G.; Steiner J. Insulin-signaling abnormalities in drug-naïve first-episode schizophrenia: Transduction protein analyses in extracellular vesicles of putative neuronal origin. European Psychiatry. 2019;62:124–129.

Oxenkrug G.; Bernstein H.-G.; Guest P.C.; van der Hart M.; Roeser J.; Summergrad P.; Steiner J. Plasma xanthurenic acid in a context of insulin resistance and obesity in schizophrenia. Schizophrenia Research. 2019;211:98–99.

Müller U.J.; Mawrin C.; Frodl T.; Dobrowolny H.; Busse S.; Bernstein H.-G.; Bogerts B.; Truebner K.; Steiner J. Reduced volumes of the external and internal globus pallidus in male heroin addicts: a postmortem study. European Archives of Psychiatry and Clinical Neuroscience. 2019;269(3):317–324.

Bernstein H.-G.; Dobrowolny H.; Bogerts B.; Keilhoff G.; Steiner J. The hypothalamus and neuropsychiatric disorders: psychiatry meets microscopy. Cell and Tissue Research. 2019;375(1):243–258.

Najjar S.; Steiner J.; Najjar A.; Bechter K. A clinical approach to new-onset psychosis associated with immune dysregulation: The concept of autoimmune psychosis. Journal of Neuroinflammation. 2018;15(1):40.

Berger M.; Juster R.-P.; Westphal S.; Amminger G.P.; Bogerts B.; Schiltz K.; Bahn S.; Steiner J.; Sarnyai Z. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis. Psychoneuroendocrinology. 2018;90:35–42.

Steiner J.; Prüß H.; Köhler S.; Hasan A.; Falkai P. Autoimmune encephalitis with psychotic symptoms: Diagnostics, warning signs and practical approach; [Autoimmunenzephalitis mit psychotischer Symptomatik: Diagnostik, Warnhinweise und praktisches Vorgehen]. Nervenarzt. 2018;89(5):530–538.

Aquino A.; Alexandrino G.L.; Guest P.C.; Augusto F.; Gomes A.F.; Murgu M.; Steiner J.; Martins-de-Souza D. Blood-based lipidomics approach to evaluate biomarkers associated with response to olanzapine, risperidone, and quetiapine treatment in schizophrenia patients. Frontiers in Psychiatry. 2018;9(MAY):209.

Bernstein H.G.; Hildebrandt J.; Dobrowolny H.; Steiner J.; Bogerts B.; Pahnke J. Corrigendum to “Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula” [Schizophr. Res. 2016 Nov;177(1–3):52–58] (S0920996416300901) (10.1016/j.schres.2016.02.036)). Schizophrenia Research. 2018;197:622–623.

Bernstein H.-G.; Dobrowolny H.; Keilhoff G.; Steiner J. Dipeptidyl peptidase IV, which probably plays important roles in Alzheimer disease (AD) pathology, is upregulated in AD brain neurons and associates with amyloid plaques. Neurochemistry International. 2018;114:55–57.

Busse M.; Kunschmann R.; Dobrowolny H.; Hoffmann J.; Bogerts B.; Steiner J.; Frodl T.; Busse S. Dysfunction of the blood-cerebrospinal fluid-barrier and N-methyl-d-aspartate glutamate receptor antibodies in dementias. European Archives of Psychiatry and Clinical Neuroscience. 2018;268(5):483–492.

Sussulini A.; Erbolato H.M.; Pessôa G.S.; Arruda M.A.Z.; Steiner J.; Martins-de-Souza D. Elemental fingerprinting of schizophrenia patient blood plasma before and after treatment with antipsychotics. European Archives of Psychiatry and Clinical Neuroscience. 2018;268(6):565–570.

Liebe T.; Li M.; Colic L.; Munk M.H.J.; Sweeney-Reed C.M.; Woelfer M.; Kretzschmar M.A.; Steiner J.; von Düring F.; Behnisch G.; Schott B.H.; Walter M. Ketamine influences the locus coeruleus norepinephrine network, with a dependency on norepinephrine transporter genotype – a placebo controlled fMRI study. NeuroImage: Clinical. 2018;20:715–723.

Jordan W.; Dobrowolny H.; Bahn S.; Bernstein H.-G.; Brigadski T.; Frodl T.; Isermann B.; Lessmann V.; Pilz J.; Rodenbeck A.; Schiltz K.; Schwedhelm E.; Tumani H.; Wiltfang J.; Guest P.C.; Steiner J. Oxidative stress in drug-naïve first episode patients with schizophrenia and major depression: effects of disease acuity and potential confounders. European Archives of Psychiatry and Clinical Neuroscience. 2018;268(2):129–143.

Bernstein H.-G.; Bogerts B.; Keilhoff G.; Steiner J. Postmortem studies indicate altered cell chemical composition of the suprachiasmatic nucleus in mood disorders. European Archives of Psychiatry and Clinical Neuroscience. 2018;268(8):871–872.

Bernstein H.-G.; Dobrowolny H.; Keilhoff G.; Bogerts B.; Steiner J. Reduced Density of DISC1 Expressing Astrocytes in the Dentate Gyrus but not in the Subventricular Zone in Schizophrenia. Neuropsychopharmacology. 2018;43(3):457–458.

Bernstein H.-G.; Keilhoff G.; Steiner J. Some notes on citrulline in the CNS. Clinical Nutrition. 2018;37(2):757.

Doolin K.; Tozzi L.; Steiner J.; Frodl T. Stress, maltreatment, inflammation, and functional brain changes in depression. Inflammation and Immunity in Depression: Basic Science and Clinical Applications. 2018;:267–285.

Müller U.J.; Schiltz K.; Mawrin C.; Dobrowolny H.; Frodl T.; Bernstein H.-G.; Bogerts B.; Truebner K.; Steiner J. Total hypothalamic volume is reduced in postmortem brains of male heroin addicts. European Archives of Psychiatry and Clinical Neuroscience. 2018;268(3):243–248.

Steiner J.; Guest P.C. A clinical study protocol to identify serum biomarkers predictive of response to antipsychotics in schizophrenia patients. Advances in Experimental Medicine and Biology. 2017;974:245–250.

Castillo-Gómez E.; Oliveira B.; Tapken D.; Bertrand S.; Klein-Schmidt C.; Pan H.; Zafeiriou P.; Steiner J.; Jurek B.; Trippe R.; Prüss H.; Zimmermann W.-H.; Bertrand D.; Ehrenreich H.; Hollmann M. All naturally occurring autoantibodies against the NMDA receptor subunit NR1 have pathogenic potential irrespective of epitope and immunoglobulin class. Molecular Psychiatry. 2017;22(12):1776–1784.

Steiner J.; Guest P.C.; Martins-de-Souza D. Application of proteomic techniques for improved stratification and treatment of schizophrenia patients. Advances in Experimental Medicine and Biology. 2017;974:3–19.

Steiner J.; Berger M.; Guest P.C.; Dobrowolny H.; Westphal S.; Schiltz K.; Sarnyai Z. Assessment of insulin resistance among drug-naive patients with first-episode schizophrenia in the context of hormonal stress axis activation. JAMA Psychiatry. 2017;74(9):968–970.

Chan M.K.; Cooper J.D.; Heilmann-Heimbach S.; Frank J.; Witt S.H.; Nöthen M.M.; Steiner J.; Rietschel M.; Bahn S. Associations between SNPs and immune-related circulating proteins in schizophrenia. Scientific Reports. 2017;7(1):12586.

Schmitt A.; Martins-de-Souza D.; Akbarian S.; Cassoli J.S.; Ehrenreich H.; Fischer A.; Fonteh A.; Gattaz W.F.; Gawlik M.; Gerlach M.; Grünblatt E.; Halene T.; Hasan A.; Hashimoto K.; Kim Y.-K.; Kirchner S.-K.; Kornhuber J.; Kraus T.F.J.; Malchow B.; Nascimento J.M.; Rossner M.; Schwarz M.; Steiner J.; Talib L.; Thibaut F.; Riederer P.; Falkai P. Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia, part III: Molecular mechanisms. World Journal of Biological Psychiatry. 2017;18(5):330–356.

Kato T.A.; Myint A.M.; Steiner J. Editorial: Minding glial cells in the novel understandings of mental illness. Frontiers in Cellular Neuroscience. 2017;11:48.

Bogerts B.; Winopal D.; Schwarz S.; Schlaaff K.; Dobrowolny H.; Mawrin C.; Frodl T.; Steiner J. Evidence of neuroinflammation in subgroups of schizophrenia and mood disorder patients: A semiquantitative postmortem study of CD3 and CD20 immunoreactive lymphocytes in several brain regions. Neurology Psychiatry and Brain Research. 2017;23:2–9.

Bernstein H.-G.; Dobrowolny H.; Keilhoff G.; Steiner J. In human brain ornithine transcarbamylase (OTC) immunoreactivity is strongly expressed in a small number of nitrergic neurons. Metabolic Brain Disease. 2017;32(6):2143–2147.

Bernstein H.-G.; Müller S.; Dobrowolny H.; Wolke C.; Lendeckel U.; Bukowska A.; Keilhoff G.; Becker A.; Trübner K.; Steiner J.; Bogerts B. Insulin-regulated aminopeptidase immunoreactivity is abundantly present in human hypothalamus and posterior pituitary gland, with reduced expression in paraventricular and suprachiasmatic neurons in chronic schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2017;267(5):427–443.

Brisch R.; Steiner J.; Mawrin C.; Krzyżanowska M.; Jankowski Z.; Gos T. Microglia in the dorsal raphe nucleus plays a potential role in both suicide facilitation and prevention in affective disorders. European Archives of Psychiatry and Clinical Neuroscience. 2017;267(5):403–415.

Li M.; Demenescu L.R.; Colic L.; Metzger C.D.; Heinze H.-J.; Steiner J.; Speck O.; Fejtova A.; Salvadore G.; Walter M. Temporal Dynamics of Antidepressant Ketamine Effects on Glutamine Cycling Follow Regional Fingerprints of AMPA and NMDA Receptor Densities. Neuropsychopharmacology. 2017;42(6):1201–1209.

Steiner J.; Guest P.C.; Rahmoune H.; Martins-De-Souza D. The application of multiplex biomarker techniques for improved stratification and treatment of schizophrenia patients. Methods in Molecular Biology. 2017;1546:19–35.

Fernandes B.S.; Williams L.M.; Steiner J.; Leboyer M.; Carvalho A.F.; Berk M. The new field of 'precision psychiatry'. BMC Medicine. 2017;15(1):80.

Müller U.J.; Schuermann F.; Dobrowolny H.; Frodl T.; Bogerts B.; Mohr S.; Steiner J. Assessment of Pharmacological Treatment Quality: Comparison of Symptom-triggered vs. Fixed-schedule Alcohol Withdrawal in Clinical Practice. Pharmacopsychiatry. 2016;49(5):199–203.

Bernstein H.-G.; Ortmann A.; Dobrowolny H.; Steiner J.; Brisch R.; Gos T.; Bogerts B. Bilaterally reduced claustral volumes in schizophrenia and major depressive disorder: a morphometric postmortem study. European Archives of Psychiatry and Clinical Neuroscience. 2016;266(1):25–33.

Chan M.K.; Cooper J.D.; Bot M.; Birkenhager T.K.; Bergink V.; Drexhage H.A.; Steiner J.; Rothermundt M.; Penninx B.W.J.H.; Bahn S. Blood-based immune-endocrine biomarkers of treatment response in depression. Journal of Psychiatric Research. 2016;83:249–259.

Fernandes B.S.; Steiner J.; Molendijk M.L.; Dodd S.; Nardin P.; Gonçalves C.-A.; Jacka F.; Köhler C.A.; Karmakar C.; Carvalho A.F.; Berk M. C-reactive protein concentrations across the mood spectrum in bipolar disorder: a systematic review and meta-analysis. The Lancet Psychiatry. 2016;3(12):1147–1156.

Fernandes B.S.; Steiner J.; Bernstein H.-G.; Dodd S.; Pasco J.A.; Dean O.M.; Nardin P.; Gonçalves C.-A.; Berk M. C-reactive protein is increased in schizophrenia but is not altered by antipsychotics: Meta-analysis and implications. Molecular Psychiatry. 2016;21(4):554–564.

Falkai P.; Malchow B.; Wetzestein K.; Nowastowski V.; Bernstein H.-G.; Steiner J.; Schneider-Axmann T.; Kraus T.; Hasan A.; Bogerts B.; Schmitz C.; Schmitt A. Decreased Oligodendrocyte and Neuron Number in Anterior Hippocampal Areas and the Entire Hippocampus in Schizophrenia: A Stereological Postmortem Study. Schizophrenia Bulletin. 2016;42:S4–S12.

Krzyżanowska M.; Steiner J.; Karnecki K.; Kaliszan M.; Brisch R.; Wiergowski M.; Braun K.; Jankowski Z.; Gos T. Decreased ribosomal DNA transcription in dorsal raphe nucleus neurons differentiates between suicidal and non-suicidal death. European Archives of Psychiatry and Clinical Neuroscience. 2016;266(3):217–224.

Krzyzanowska M.; Steiner J.; Brisch R.; Mawrin C.; Busse S.; Karnecki K.; Jankowski Z.; Gos T. Decreased ribosomal DNA transcription in dorsal raphe nucleus neurons is specific for suicide regardless of psychiatric diagnosis. Psychiatry Research. 2016;241:43–46.

Cassoli J.S.; Iwata K.; Steiner J.; Guest P.C.; Turck C.W.; Nascimento J.M.; Martins-de-Souza D. Effect of MK-801 and clozapine on the proteome of cultured human oligodendrocytes. Frontiers in Cellular Neuroscience. 2016;10(MAR2016):52.

Steiner J.; Brisch R.; Schiltz K.; Dobrowolny H.; Mawrin C.; Krzyżanowska M.; Bernstein H.-G.; Jankowski Z.; Braun K.; Schmitt A.; Bogerts B.; Gos T. GABAergic system impairment in the hippocampus and superior temporal gyrus of patients with paranoid schizophrenia: A post-mortem study. Schizophrenia Research. 2016;177(1-3):10–17.

Chan M.K.; Cooper J.D.; Bot M.; Steiner J.; Penninx B.W.J.H.; Bahn S. Identification of an Immune-Neuroendocrine Biomarker Panel for Detection of Depression: A Joint Effects Statistical Approach. Neuroendocrinology. 2016;103(6):693–710.

Bernstein H.-G.; Jauch E.; Dobrowolny H.; Mawrin C.; Steiner J.; Bogerts B. Increased density of DISC1-immunoreactive oligodendroglial cells in fronto-parietal white matter of patients with paranoid schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2016;266(6):495–504.

Fernandes B.S.; Dash S.; Jacka F.; Dodd S.; Carvalho A.F.; Köhler C.A.; Steiner J.; da Graça Cantarelli M.; Nardin P.; Gonçalves C.-A.; Berk M. Leptin in bipolar disorder: A systematic review and meta-analysis. European Psychiatry. 2016;35:1–7.

Bernstein H.-G.; Hildebrandt J.; Dobrowolny H.; Steiner J.; Bogerts B.; Pahnke J. Morphometric analysis of the cerebral expression of ATP-binding cassette transporter protein ABCB1 in chronic schizophrenia: Circumscribed deficits in the habenula. Schizophrenia Research. 2016;177(1-3):52–58.

Müller U.J.; Sturm V.; Voges J.; Heinze H.-J.; Galazky I.; Büntjen L.; Heldmann M.; Frodl T.; Steiner J.; Bogerts B. Nucleus Accumbens Deep Brain Stimulation for Alcohol Addiction - Safety and Clinical Long-term Results of a Pilot Trial. Pharmacopsychiatry. 2016;49(4):170–173.

Falkai P.; Steiner J.; Malchow B.; Shariati J.; Knaus A.; Bernstein H.-G.; Schneider-Axmann T.; Kraus T.; Hasan A.; Bogerts B.; Schmitt A. Oligodendrocyte and interneuron density in hippocampal subfields in schizophrenia and association of oligodendrocyte number with cognitive deficits. Frontiers in Cellular Neuroscience. 2016;10(MAR2016):78.

Tomasik J.; Schwarz E.; Lago S.G.; Rothermundt M.; Leweke F.M.; van Beveren N.J.M.; Guest P.C.; Rahmoune H.; Steiner J.; Bahn S. Pretreatment levels of the fatty acid handling proteins H-FABP and CD36 predict response to olanzapine in recent-onset schizophrenia patients. Brain, Behavior, and Immunity. 2016;52:178–186.

Uhrig S.; Hirth N.; Broccoli L.; von Wilmsdorff M.; Bauer M.; Sommer C.; Zink M.; Steiner J.; Frodl T.; Malchow B.; Falkai P.; Spanagel R.; Hansson A.C.; Schmitt A. Reduced oxytocin receptor gene expression and binding sites in different brain regions in schizophrenia: A post-mortem study. Schizophrenia Research. 2016;177(1-3):59–66.

Schümberg K.; Polyakova M.; Steiner J.; Schroeter M.L. Serum s100b is related to illness duration and clinical symptoms in schizophrenia—A meta-regression analysis. Frontiers in Cellular Neuroscience. 2016;10(FEB):46.

Castillo-Gomez E.; Kästner A.; Steiner J.; Schneider A.; Hettling B.; Poggi G.; Ostehr K.; Uhr M.; Asif A.R.; Matzke M.; Schmidt U.; Pfander V.; Hammer C.; Schulz T.F.; Binder L.; Stöcker W.; Weber F.; Ehrenreich H. The brain as immunoprecipitator of serum autoantibodies against N-Methyl-D-aspartate receptor subunit NR1. Annals of Neurology. 2016;79(1):144–151.

Haenisch F.; Cooper J.D.; Reif A.; Kittel-Schneider S.; Steiner J.; Leweke F.M.; Rothermundt M.; van Beveren N.J.M.; Crespo-Facorro B.; Niebuhr D.W.; Cowan D.N.; Weber N.S.; Yolken R.H.; Penninx B.W.J.H.; Bahn S. Towards a blood-based diagnostic panel for bipolar disorder. Brain, Behavior, and Immunity. 2016;52:49–57.

Steiner J.; Schiltz K.; Bernstein H.-G.; Bogerts B. Antineuronal antibodies against neurotransmitter receptors and synaptic proteins in schizophrenia: Current knowledge and clinical implications. CNS Drugs. 2015;29(3):197–206.

Brisch R.; Bielau H.; Saniotis A.; Wolf R.; Bogerts B.; Krell D.; Steiner J.; Braun K.; Krzyzanowska M.; Krzyzanowski M.; Jankowski Z.; Kaliszan M.; Bernstein H.-G.; Gos T. Calretinin and parvalbumin in schizophrenia and affective disorders: A mini-review, a perspective on the evolutionary role of calretinin in schizophrenia, and a preliminary post-mortem study of calretinin in the septal nuclei. Frontiers in Cellular Neuroscience. 2015;9(OCTOBER):393.

Busse M.; Busse S.; Myint A.M.; Gos T.; Dobrowolny H.; Müller U.J.; Bogerts B.; Bernstein H.-G.; Steiner J. Decreased quinolinic acid in the hippocampus of depressive patients: evidence for local anti-inflammatory and neuroprotective responses?. European Archives of Psychiatry and Clinical Neuroscience. 2015;265(4):321–329.

Chan M.K.; Krebs M.-O.; Cox D.; Guest P.C.; Yolken R.H.; Rahmoune H.; Rothermundt M.; Steiner J.; Leweke F.M.; Van Beveren N.J.M.; Niebuhr D.W.; Weber N.S.; Cowan D.N.; Suarez-Pinilla P.; Crespo-Facorro B.; Mam-Lam-Fook C.; Bourgin J.; Wenstrup R.J.; Kaldate R.R.; Cooper J.D.; Bahn S. Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset. Translational Psychiatry. 2015;5(7):e601.

Bernstein H.-G.; Lindquist J.A.; Keilhoff G.; Dobrowolny H.; Brandt S.; Steiner J.; Bogerts B.; Mertens P.R. Differential distribution of Y-box-binding protein 1 and cold shock domain protein A in developing and adult human brain. Brain Structure and Function. 2015;220(4):2235–2245.

Bernstein H.-G.; Dobrowolny H.; Trübner K.; Steiner J.; Bogerts B.; Hoffmann W. Differential regional and cellular distribution of TFF3 peptide in the human brain. Amino Acids. 2015;47(5):1053–1063.

Bernstein H.-G.; Keilhoff G.; Steiner J.; Laube G.; Bogerts B. Downregulation of Neuregulin 1-ErbB4 Signaling and Antidepressant Properties of Ketamine: ErbB4 Expressing Pyramidal Neurons May Play a Role. Journal of Molecular Neuroscience. 2015;55(2):372–373.

Bernstein H.-G.; Lindquist J.A.; Keilhoff G.; Dobrowolny H.; Brandt S.; Steiner J.; Bogerts B.; Mertens P.R. Erratum: Differential distribution of Y-box-binding protein 1 and cold shock domain protein A in developing and adult human brain [Brain Struct Funct, DOI 10.1007/s00429-014-0786-9]. Brain Structure and Function. 2015;220(4):2247.

Busse S.; Steiner J.; Alter J.; Dobrowolny H.; Mawrin C.; Bogerts B.; Hartig R.; Busse M. Expression of HLA-DR, CD80, and CD86 in Healthy Aging and Alzheimer's Disease. Journal of Alzheimer's Disease. 2015;47(1):177–184.

Bernstein H.-G.; Steiner J.; Guest P.C.; Dobrowolny H.; Bogerts B. Glial cells as key players in schizophrenia pathology: Recent insights and concepts of therapy. Schizophrenia Research. 2015;161(1):4–18.

Schwarz E.; Steiner J.; Guest P.C.; Bogerts B.; Bahn S. Investigation of molecular serum profiles associated with predisposition to antipsychotic-induced weight gain. World Journal of Biological Psychiatry. 2015;16(1):22–30.

Guest P.C.; Iwata K.; Kato T.A.; Steiner J.; Schmitt A.; Turck C.W.; Martins-De-Souza D. MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: Insights for schizophrenia. Frontiers in Cellular Neuroscience. 2015;9(MAY).

Steiner J.; Bogerts B. N-Methyl-d-aspartate receptor autoantibodies in schizophrenia and affective disorders. Schizophrenia Research. 2015;162(1-3):291.

Fernandes B.S.; Steiner J.; Berk M.; Molendijk M.L.; Gonzalez-Pinto A.; Turck C.W.; Nardin P.; Gonçalves C.-A. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: Meta-analysis and implications. Molecular Psychiatry. 2015;20(9):1108–1119.

Bernstein H.-G.; Jäger K.; Dobrowolny H.; Steiner J.; Keilhoff G.; Bogerts B.; Laube G. Possible sources and functions of l-homoarginine in the brain: Review of the literature and own findings. Amino Acids. 2015;47(9):1729–1740.

Müller U.J.; Truebner K.; Schiltz K.; Kuhn J.; Mawrin C.; Dobrowolny H.; Bernstein H.-G.; Bogerts B.; Steiner J. Postmortem volumetric analysis of the nucleus accumbens in male heroin addicts: implications for deep brain stimulation. European Archives of Psychiatry and Clinical Neuroscience. 2015;265(8):647–653.

Zerche M.; Weissenborn K.; Ott C.; Dere E.; Asif A.R.; Worthmann H.; Hassouna I.; Rentzsch K.; Tryc A.B.; Dahm L.; Steiner J.; Binder L.; Wiltfang J.; Sirén A.-L.; Stöcker W.; Ehrenreich H. Preexisting Serum Autoantibodies Against the NMDAR Subunit NR1 Modulate Evolution of Lesion Size in Acute Ischemic Stroke. Stroke. 2015;46(5):1180–1186.

Bernstein H.-G.; Meyer-Lotz G.; Dobrowolny H.; Bannier J.; Steiner J.; Walter M.; Bogerts B. Reduced density of glutamine synthetase immunoreactive astrocytes in different cortical areas in major depression but not in bipolar I disorder. Frontiers in Cellular Neuroscience. 2015;9(AUGUST):273.

Ehrenreich H.; Steiner J. Reply. Annals of Neurology. 2015;77(1):184.

Krzyzanowska M.; Steiner J.; Brisch R.; Mawrin C.; Busse S.; Braun K.; Jankowski Z.; Bernstein H.-G.; Bogerts B.; Gos T. Ribosomal DNA transcription in dorsal raphe nucleus neurons is increased in residual schizophrenia compared to depressed patients with affective disorders. Psychiatry Research. 2015;230(2):233–241.

Krzyżanowska M.; Steiner J.; Brisch R.; Mawrin C.; Busse S.; Braun K.; Jankowski Z.; Bernstein H.-G.; Bogerts B.; Gos T. Ribosomal DNA transcription in the dorsal raphe nucleus is increased in residual but not in paranoid schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2015;265(2):117–126.

Bot M.; Chan M.K.; Jansen R.; Lamers F.; Vogelzangs N.; Steiner J.; Leweke F.M.; Rothermundt M.; Cooper J.; Bahn S.; Penninx B.W.J.H. Serum proteomic profiling of major depressive disorder. Translational Psychiatry. 2015;5(7):e599.

Malchow B.; Strocka S.; Frank F.; Bernstein H.-G.; Steiner J.; Schneider-Axmann T.; Hasan A.; Reich-Erkelenz D.; Schmitz C.; Bogerts B.; Falkai P.; Schmitt A. Stereological investigation of the posterior hippocampus in affective disorders. Journal of Neural Transmission. 2015;122(7):1019–1033.

Busse S.; Steiner J.; Glorius S.; Dobrowolny H.; Greiner-Bohl S.; Mawrin C.; Bommhardt U.; Hartig R.; Bogerts B.; Busse M. VGF expression by T lymphocytes in patients with Alzheimer's disease. Oncotarget. 2015;6(17):14843–14851.

Müller U.J.; Teegen B.; Probst C.; Bernstein H.-G.; Busse S.; Bogerts B.; Schiltz K.; Stoecker W.; Steiner J. Absence of dopamine receptor serum autoantibodies in schizophrenia patients with an acute disease episode. Schizophrenia Research. 2014;158(1-3):272–274.

Busse S.; Steiner J.; Micheel J.; Dobrowolny H.; Mawrin C.; Krause T.J.; Adamaszek M.; Bogerts B.; Bommhardt U.; Hartig R.; Busse M. Age-related increase of VGF-expression in T lymphocytes. Aging. 2014;6(6):440–453.

Steiner J.; Martins-de-Souza D.; Schiltz K.; Sarnyai Z.; Westphal S.; Isermann B.; Dobrowolny H.; Turck C.W.; Bogerts B.; Bernstein H.-G.; Horvath T.L.; Schild L.; Keilhoff G. Clozapine promotes glycolysis and myelin lipid synthesis in cultured oligodendrocytes. Frontiers in Cellular Neuroscience. 2014;8:384.

de Witte L.; Tomasik J.; Schwarz E.; Guest P.C.; Rahmoune H.; Steiner J.; Rothermundt M.; Leweke F.M.; van Beveren N.J.; Kahn R.S.; Bahn S. Corrigendum to "Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment" [Schizophr. Res. 154 (1-3) (2014) 23-29]. Schizophrenia Research. 2014;157(1-3):321.

Brisch R.; Saniotis A.; Wolf R.; Bielau H.; Bernstein H.G.; Steiner J.; Bogerts B.; Braun K.; Jankowski Z.; Kumaratilake J.; Henneberg M.; Gos T. Corrigendum to The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: Old fashioned, but still in vogue [Front Psychiatry 5, 47] DOI:10.3389/fpsyt.2014.00047. Frontiers in Psychiatry. 2014;5(AUG):Article 110.

Steiner J.; Bernstein H.-G.; Schiltz K.; Haase T.; Meyer-Lotz G.; Dobrowolny H.; Müller U.J.; Martins-de-Souza D.; Borucki K.; Schroeter M.L.; Isermann B.; Bogerts B.; Westphal S. Decrease of serum S100B during an oral glucose tolerance test correlates inversely with the insulin response. Psychoneuroendocrinology. 2014;39(1):33–38.

Fernandes B.S.; Berk M.; Turck C.W.; Steiner J.; Gonçalves C.-A. Decreased peripheral brain-derived neurotrophic factor levels are a biomarker of disease activity in major psychiatric disorders: A comparative meta-analysis. Molecular Psychiatry. 2014;19(7):749–751.

Müller U.J.; Bogerts B.; Voges J.; Galazky I.; Kohl S.; Heinze H.-J.; Kuhn J.; Steiner J. Deep brain stimulation in psychiatry: Ethical aspects; [Tiefe Hirnstimulation in der Psychiatrie: Ethische Aspekte]. Psychiatrische Praxis. 2014;41(SUPPL. 1):S38–S43.

Bernstein H.-G.; Bannier J.; Meyer-Lotz G.; Steiner J.; Keilhoff G.; Dobrowolny H.; Walter M.; Bogerts B. Distribution of immunoreactive glutamine synthetase in the adult human and mouse brain. Qualitative and quantitative observations with special emphasis on extra-astroglial protein localization. Journal of Chemical Neuroanatomy. 2014;61:33–50.

Schroeter M.L.; Steiner J.; Schönknecht P.; Mueller K. Further evidence for a role of S100B in mood disorders: A human gene expression mega-analysis. Journal of Psychiatric Research. 2014;53(1):84–86.

Schwarz E.; Van Beveren N.J.M.; Ramsey J.; Leweke F.M.; Rothermundt M.; Bogerts B.; Steiner J.; Guest P.C.; Bahn S. Identification of subgroups of Schizophrenia patients with changes in either immune or growth factor and hormonal pathways. Schizophrenia Bulletin. 2014;40(4):787–795.

Steiner J.; Bernstein H.-G.; Schiltz K.; Müller U.J.; Westphal S.; Drexhage H.A.; Bogerts B. Immune system and glucose metabolism interaction in schizophrenia: A chicken-egg dilemma. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 2014;48:287–294.

Bernstein H.-G.; Trübner K.; Krebs P.; Dobrowolny H.; Bielau H.; Steiner J.; Bogerts B. Increased densities of nitric oxide synthase expressing neurons in the temporal cortex and the hypothalamic paraventricular nucleus of polytoxicomanic heroin overdose victims: Possible implications for heroin neurotoxicity. Acta Histochemica. 2014;116(1):182–190.

Steiner J.; Gos T.; Handerer I.; Bernstein H.-G.; Bogerts B. Is activated microglia of pathophysiological significance in patients with schizophrenia, depression or suicidality?; [Ist eine Aktivierung von Mikrogliazellen von pathophysiologischer Bedeutung?: Patienten mit Schizophrenie, Depression oder Suizidalität]. Nervenheilkunde. 2014;33(11):790–796.

Van Tol M.-J.; Li M.; Metzger C.D.; Hailla N.; Horn D.I.; Li W.; Heinze H.J.; Bogerts B.; Steiner J.; He H.; Walter M. Local cortical thinning links to resting-state disconnectivity in major depressive disorder. Psychological Medicine. 2014;44(10):2053–2065.

Bernstein H.-G.; Steiner J.; Bogerts B.; Stricker R.; Reiser G. Nardilysin, ADAM10, and Alzheimer's disease: Of mice and men. Neurobiology of Aging. 2014;35(3):e1.

Steiner J.; Teegen B.; Schiltz K.; Bernstein H.-G.; Stoecker W.; Bogerts B. Prevalence of N-methyl-D-aspartate receptor autoantibodies in the peripheral blood: Healthy control samples revisited. JAMA Psychiatry. 2014;71(7):838–839.

Stelzhammer V.; Haenisch F.; Chan M.K.; Cooper J.D.; Steiner J.; Steeb H.; Martins-de-Souza D.; Rahmoune H.; Guest P.C.; Bahn S. Proteomic changes in serum of first onset, antidepressant drug-naïve major depression patients. International Journal of Neuropsychopharmacology. 2014;17(10):1599–1608.

Gos T.; Myint A.-M.; Schiltz K.; Meyer-Lotz G.; Dobrowolny H.; Busse S.; Müller U.J.; Mawrin C.; Bernstein H.-G.; Bogerts B.; Steiner J. Reduced microglial immunoreactivity for endogenous NMDA receptor agonist quinolinic acid in the hippocampus of schizophrenia patients. Brain, Behavior, and Immunity. 2014;41(1):59–64.

Steiner J.; Schmitt A.; Schroeter M.L.; Bogerts B.; Falkai P.; Turck C.W.; Martins-De-Souza D. S100B is downregulated in the nuclear proteome of schizophrenia corpus callosum. European Archives of Psychiatry and Clinical Neuroscience. 2014;264(4):311–316.

Dahm L.; Ott C.; Steiner J.; Stepniak B.; Teegen B.; Saschenbrecker S.; Hammer C.; Borowski K.; Begemann M.; Lemke S.; Rentzsch K.; Probst C.; Martens H.; Wienands J.; Spalletta G.; Weissenborn K.; Stöcker W.; Ehrenreich H. Seroprevalence of autoantibodies against brain antigens in health and disease. Annals of Neurology. 2014;76(1):82–94.

Busse S.; Busse M.; Brix B.; Probst C.; Genz A.; Bogerts B.; Stoecker W.; Steiner J. Seroprevalence of n-methyl-d-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients. European Archives of Psychiatry and Clinical Neuroscience. 2014;264(6):545–550.

Brisch R.; Saniotis A.; Wolf R.; Bielau H.; Bernstein H.G.; Steiner J.; Bogerts B.; Braun K.; Jankowski Z.; Henneberg M.; Gos T. The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: Old fashioned, but still in vogue. Frontiers in Psychiatry. 2014;5(APR):Article 47.

Bernstein H.-G.; Steiner J.; Dobrowolny H.; Bogerts B. ZNF804A protein is widely expressed in human brain neurons: Possible implications on normal brain structure and pathomorphologic changes in schizophrenia. Schizophrenia Bulletin. 2014;40(3):499–500.

Bernstein H.-G.; Keilhoff G.; Lendeckel U.; Steiner J.; Bogerts B. Concerning HB-EGF Brain Levels in Schizophrenia: Cellular Distribution of Putative Sheddases May Matter. CNS Neuroscience and Therapeutics. 2013;19(2):136–137.

Steiner J.; Walter M.; Gos T.; Guillemin G.J.; Bernstein H.-G.; Sarnyai Z.; Mawrin C.; Brisch R.; Bielau H.; zu Schwabedissen L.M.; Bogerts B.; Myint A.-M. Correction to Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission? [Journal of Neuroinflammation (2013) 10, 34] 10.1186/1742-2094-10-34. Journal of Neuroinflammation. 2013;10:799.

Bernstein H.-G.; Stricker R.; Zschiebsch K.; Müller S.; Dobrowolny H.; Steiner J.; Bogerts B.; Reiser G. Decreased expression of nardilysin in SH-SY5Y cells under ethanol stress and reduced density of nardilysin-expressing neurons in brains of alcoholics. Journal of Psychiatric Research. 2013;47(3):343–349.

Müller U.J.; Voges J.; Steiner J.; Galazky I.; Heinze H.-J.; Möller M.; Pisapia J.; Halpern C.; Caplan A.; Bogerts B.; Kuhn J. Deep brain stimulation of the nucleus accumbens for the treatment of addiction. Annals of the New York Academy of Sciences. 2013;1282(1):119–128.

Jäger K.; Wolf S.; Dobrowolny H.; Steiner J.; Nave H.; Maronde E.; Bogerts B.; Bernstein H.-G. Differential topochemistry of three cationic amino acid transporter proteins, hCAT1, hCAT2 and hCAT3, in the adult human brain. Amino Acids. 2013;44(2):423–433.

Osoba A.; Hänggi J.; Li M.; Horn D.I.; Metzger C.; Eckert U.; Kaufmann J.; Zierhut K.; Steiner J.; Schiltz K.; Heinze H.-J.; Bogerts B.; Walter M. Disease severity is correlated to tract specific changes of fractional anisotropy in MD and CM thalamus - A DTI study in major depressive disorder. Journal of Affective Disorders. 2013;149(1-3):116–128.

Bernstein H.-G.; Tausch A.; Wagner R.; Steiner J.; Seeleke P.; Walter M.; Dobrowolny H.; Bogerts B. Disruption of glutamate-glutamine-GABA cycle significantly impacts on suicidal behaviour: Survey of the literature and own findings on glutamine synthetase. CNS and Neurological Disorders - Drug Targets. 2013;12(7):900–913.

Ramsey J.M.; Schwarz E.; Guest P.C.; Van Beveren N.J.M.; Leweke F.M.; Rothermundt M.; Bogerts B.; Steiner J.; Bahn S. Distinct molecular phenotypes in male and female schizophrenia patients. PLoS ONE. 2013;8(11):e78729.

Zierhut K.C.; Schulte-Kemna A.; Kaufmann J.; Steiner J.; Bogerts B.; Schiltz K. Distinct structural alterations independently contributing to working memory deficits and symptomatology in paranoid schizophrenia. Cortex. 2013;49(4):1063–1072.

Bernstein H.-G.; Dobrowolny H.; Steiner J.; Bogerts B. Heart Failure - An identified but largely ignored source of errors in postmortem brain volume studies. Journal of Cardiac Failure. 2013;19(8):600.

Zierhut K.C.; Graßmann R.; Kaufmann J.; Steiner J.; Bogerts B.; Schiltz K. Hippocampal CA1 deformity is related to symptom severity and antipsychotic dosage in schizophrenia. Brain. 2013;136(3):804–814.

Bernstein H.-G.; Dobrowolny H.; Schott B.H.; Gorny X.; Becker V.; Steiner J.; Seidenbecher C.I.; Bogerts B. Increased density of AKAP5-expressing neurons in the anterior cingulate cortex of subjects with bipolar disorder. Journal of Psychiatric Research. 2013;47(6):699–705.

Mosebach J.; Keilhoff G.; Gos T.; Schiltz K.; Schoeneck L.; Dobrowolny H.; Mawrin C.; Müller S.; Schroeter M.L.; Bernstein H.-G.; Bogerts B.; Steiner J. Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: A regenerative attempt to compensate oligodendrocyte loss?. Journal of Psychiatric Research. 2013;47(8):1069–1079.

Steiner J.; Walter M.; Glanz W.; Sarnyai Z.; Bernstein H.-G.; Vielhaber S.; Kästner A.; Skalej M.; Jordan W.; Schiltz K.; Klingbeil C.; Wandinger K.-P.; Bogerts B.; Stoecker W. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: Specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis. JAMA Psychiatry. 2013;70(3):271–278.

Yang S.; Yang Z.; Fischer K.; Zhong K.; Stadler J.; Godenschweger F.; Steiner J.; Heinze H.-J.; Bernstein H.-G.; Bogerts B.; Mawrin C.; Reutens D.C.; Speck O.; Walter M. Integration of ultra-high field MRI and histology for connectome based research of brain disorders. Frontiers in Neuroanatomy. 2013;7(SEP):31.

Bernstein H.-G.; Stricker R.; Dobrowolny H.; Steiner J.; Bogerts B.; Trübner K.; Reiser G. Nardilysin in human brain diseases: Both friend and foe. Amino Acids. 2013;45(2):269–278.

Steiner J.; Gos T.; Bogerts B.; Bielau H.; Drexhage H.A.; Bernstein H.-G. Possible impact of microglial cells and the monocyte-macrophage system on suicidal behavior. CNS and Neurological Disorders - Drug Targets. 2013;12(7):971–979.

Gos T.; Steiner J.; Jankowski Z.; Bogerts B. Postmortem-assessed impairment of neuronal activity in depression: The dominant impact of suicide. CNS and Neurological Disorders - Drug Targets. 2013;12(7):930–935.

Steiner J.; Bernstein H.-G.; Bogerts B.; Gonçalves C.-A. Potential roles of S100B in schizophrenia; [Os possíveis papéis da S100B na esquizofrenia]. Revista de Psiquiatria Clinica. 2013;40(1):35–40.

Gos T.; Steiner J.; Krell D.; Bielau H.; Mawrin C.; Krzyzanowski M.; Brisch R.; Pieśniak D.; Bernstein H.-G.; Jankowski Z.; Braun K.; Bogerts B. Ribosomal DNA transcription in the anterior cingulate cortex is decreased in unipolar but not bipolar I depression. Psychiatry Research. 2013;210(1):338–345.

Gos T.; Schroeter M.L.; Lessel W.; Bernstein H.-G.; Dobrowolny H.; Schiltz K.; Bogerts B.; Steiner J. S100B-immunopositive astrocytes and oligodendrocytes in the hippocampus are differentially afflicted in unipolar and bipolar depression: A postmortem study. Journal of Psychiatric Research. 2013;47(11):1694–1699.

Schroeter M.L.; Sacher J.; Steiner J.; Schoenknecht P.; Mueller K. Serum S100B represents a new biomarker for mood disorders. Current Drug Targets. 2013;14(11):1237–1248.

Müller S.; Lendeckel U.; Dobrowolny H.; Steiner J.; Bogerts B.; Bernstein H.-G. Some notes on insulin-regulated aminopeptidase in depression. International Journal of Neuropsychopharmacology. 2013;16(8):1877–1878.

Iwata K.; Café-Mendes C.C.; Schmitt A.; Steiner J.; Manabe T.; Matsuzaki H.; Falkai P.; Turck C.W.; Martins-de-Souza D. The human oligodendrocyte proteome. Proteomics. 2013;13(23-24):3548–3553.

Bielau H.; Brisch R.; Gos T.; Dobrowolny H.; Baumann B.; Mawrin C.; Kreutzmann P.; Bernstein H.-G.; Bogerts B.; Steiner J. Volumetric analysis of the hypothalamus, amygdala and hippocampus in non-suicidal and suicidal mood disorder patients - A post-mortem study. CNS and Neurological Disorders - Drug Targets. 2013;12(7):914–920.

Bernstein H.-G.; Kirches E.; Bogerts B.; Lendeckel U.; Keilhoff G.; Zempeltzi M.; Steiner J.; Tenbrock K.; Dobrowolny H.; Kyttaris V.C.; Mawrin C. Wide distribution of CREM immunoreactivity in adult and fetal human brain, with an increased expression in dentate gyrus neurons of Alzheimer's as compared to normal aging brains. Amino Acids. 2013;45(6):1373–1383.

Bernstein H.-G.; Klix M.; Dobrowolny H.; Brisch R.; Steiner J.; Bielau H.; Gos T.; Bogerts B. A postmortem assessment of mammillary body volume, neuronal number and densities, and fornix volume in subjects with mood disorders. European Archives of Psychiatry and Clinical Neuroscience. 2012;262(8):637–646.

Bernstein H.-G.; Stich C.; Jäger K.; Dobrowolny H.; Wick M.; Steiner J.; Veh R.; Bogerts B.; Laube G. Agmatinase, an inactivator of the putative endogenous antidepressant agmatine, is strongly upregulated in hippocampal interneurons of subjects with mood disorders. Neuropharmacology. 2012;62(1):237–246.

Steiner J.; Bogerts B.; Sarnyai Z.; Walter M.; Gos T.; Bernstein H.-G.; Myint A.-M. Bridging the gap between the immune and glutamate hypotheses of schizophrenia and major depression: Potential role of glial NMDA receptor modulators and impaired bloodbrain barrier integrity. World Journal of Biological Psychiatry. 2012;13(7):482–492.

Gos T.; Steiner J.; Bielau H.; Dobrowolny H.; Gunther K.; Mawrin C.; Krzyzanowski M.; Hauser R.; Brisch R.; Bernstein H.-G.; Jankowski Z.; Braun K.; Bogerts B. Differences between unipolar and bipolar i depression in the quantitative analysis of glutamic acid decarboxylase-immunoreactive neuropil. European Archives of Psychiatry and Clinical Neuroscience. 2012;262(8):647–655.

Busse S.; Busse M.; Schiltz K.; Bielau H.; Gos T.; Brisch R.; Mawrin C.; Schmitt A.; Jordan W.; Müller U.J.; Bernstein H.-G.; Bogerts B.; Steiner J. Different distribution patterns of lymphocytes and microglia in the hippocampus of patients with residual versus paranoid schizophrenia: Further evidence for disease course-related immune alterations?. Brain, Behavior, and Immunity. 2012;26(8):1273–1279.

Schwarz E.; Guest P.C.; Rahmoune H.; Harris L.W.; Wang L.; Leweke F.M.; Rothermundt M.; Bogerts B.; Koethe D.; Kranaster L.; Ohrmann P.; Suslow T.; McAllister G.; Spain M.; Barnes A.; Van Beveren N.J.M.; Baron-Cohen S.; Steiner J.; Torrey F.E.; Yolken R.H.; Bahn S. Identification of a biological signature for schizophrenia in serum. Molecular Psychiatry. 2012;17(5):494–502.

Schwarz E.; Guest P.C.; Steiner J.; Bogerts B.; Bahn S. Identification of blood-based molecular signatures for prediction of response and relapse in schizophrenia patients. Translational Psychiatry. 2012;2:e82.

Bielau H.; Brisch R.; Bernard-Mittelstaedt J.; Dobrowolny H.; Gos T.; Baumann B.; Mawrin C.; Bernstein H.-G.; Bogerts B.; Steiner J. Immunohistochemical evidence for impaired nitric oxide signaling of the locus coeruleus in bipolar disorder. Brain Research. 2012;1459:91–99.

Bernstein H.-G.; Smalla K.-H.; Dürrschmidt D.; Keilhoff G.; Dobrowolny H.; Steiner J.; Schmitt A.; Kreutz M.R.; Bogerts B. Increased density of prohibitin-immunoreactive oligodendrocytes in the dorsolateral prefrontal white matter of subjects with schizophrenia suggests extraneuronal roles for the protein in the disease. NeuroMolecular Medicine. 2012;14(4):270–280.

Steiner J.; Westphal S.; Schroeter M.L.; Schiltz K.; Jordan W.; Müller U.J.; Bernstein H.-G.; Bogerts B.; Schmidt R.E.; Jacobs R. Increased S100B+ NK cell counts in acutely ill schizophrenia patients are correlated with the free cortisol index, but not with S100B serum levels. Brain, Behavior, and Immunity. 2012;26(4):564–567.

Ramsey J.M.; Schwarz E.; Guest P.C.; van Beveren N.J.M.; Leweke F.M.; Rothermundt M.; Bogerts B.; Steiner J.; Ruta L.; Baron-Cohen S.; Bahn S. Molecular Sex Differences in Human Serum. PLoS ONE. 2012;7(12):e51504.

Eckert U.; Metzger C.D.; Buchmann J.E.; Kaufmann J.; Osoba A.; Li M.; Safron A.; Liao W.; Steiner J.; Bogerts B.; Walter M. Preferential networks of the mediodorsal nucleus and centromedian-parafascicular complex of the thalamus-A DTI tractography study. Human Brain Mapping. 2012;33(11):2627–2637.

Busse S.; Bernstein H.-G.; Busse M.; Bielau H.; Brisch R.; Mawrin C.; Müller S.; Zoltan Sarnyai; Gos T.; Bogerts B.; Steiner J. Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: A potential link to impaired growth factor signaling and energy homeostasis. European Archives of Psychiatry and Clinical Neuroscience. 2012;262(5):365–374.

Brisch R.; Bielau H.; Gos T.; Steiner J.; Jankowski Z.; Wolf R.; Bogerts B.; Bernstein H.-G. Review: Involvement of the Cavum Septi Pellucidi and the Fornix in the Neuropathology of Schizophrenia and Affective Disorders. Current Psychiatry Reviews. 2012;8(2):161–167.

Beumer W.; Gibney S.M.; Drexhage R.C.; Pont-Lezica L.; Doorduin J.; Klein H.C.; Steiner J.; Connor T.J.; Harkin A.; Versnel M.A.; Drexhage H.A. The immune theory of psychiatric diseases: A key role for activated microglia and circulating monocytes. Journal of Leukocyte Biology. 2012;92(5):959–975.

Streitbürger D.-P.; Arelin K.; Kratzsch J.; Thiery J.; Steiner J.; Villringer A.; Mueller K.; Schroeter M.L. Validating serum S100B and neuron-specific enolase as biomarkers for the human brain - A combined serum, gene expression and MRI study. PLoS ONE. 2012;7(8):e43284.

Brisch R.; Bernstein H.-G.; Dobrowolny H.; Krell D.; Stauch R.; Trübner K.; Steiner J.; Ghabriel M.N.; Bielau H.; Wolf R.; Winter J.; Kropf S.; Gos T.; Bogerts B. A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: Reduced neuronal density in the lateral septal nucleus in bipolar disorder. European Archives of Psychiatry and Clinical Neuroscience. 2011;261(1):47–58.

Walter M.; Horn D.I.; Bogerts B.; Steiner J. Aberrant resting state mechanisms in major depression - Evidence from histopathology and non invasive imaging reveal the importance of glial dysfunction; [Charakteristische veränderungen des ruhezustandes bei depression - Bildgebung, histopathologie und resting state fMRT]. Nervenheilkunde. 2011;30(11):914–921.

Guest P.C.; Schwarz E.; Krishnamurthy D.; Harris L.W.; Leweke F.M.; Rothermundt M.; van Beveren N.J.M.; Spain M.; Barnes A.; Steiner J.; Rahmoune H.; Bahn S. Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology. 2011;36(7):1092–1096.

Jordan W.; Bleich S.; Cohrs S.; Von Einsiedel R.; Falkai P.; Großkopf V.; Hauth I.; Steiner J.; Adler L. Definition of the core area of medical services in the psychiatric- psychotherapeutic field the prerequisite for any delegation; [Definition des Kernbereichs ärztlicher Tätigkeit im psychiatrisch-psychotherapeutischen Fachgebiet Voraussetzung für jede Delegation]. Psychiatrische Praxis. 2011;38(SUPPL. 2):S8–S15.

Bernstein H.-G.; Lendeckel U.; Steiner J.; Bogerts B. Do elevated glucocorticoids contribute to reduced cerebral expression of insulin-degrading enzyme in schizophrenia?. Journal of Psychiatric Research. 2011;45(12):1655–1656.

Schroeter M.L.; Steiner J.; Mueller K. Glial pathology is modified by age in mood disorders - A systematic meta-analysis of serum S100B in vivo studies. Journal of Affective Disorders. 2011;134(1-3):32–38.

Steiner J.; Marquardt N.; Pauls I.; Schiltz K.; Rahmoune H.; Bahn S.; Bogerts B.; Schmidt R.E.; Jacobs R. Human CD8 + T cells and NK cells express and secrete S100B upon stimulation. Brain, Behavior, and Immunity. 2011;25(6):1233–1241.

Schreiber S.; Bernstein H.-G.; Fendrich R.; Stauch R.; Ketzler B.; Dobrowolny H.; Steiner J.; Schreiber F.; Bogerts B. Increased density of GAD65/67 immunoreactive neurons in the posterior subiculum and parahippocampal gyrus in treated patients with chronic schizophrenia. World Journal of Biological Psychiatry. 2011;12(1):57–65.

Jordan W.; Adler L.; Bleich S.; Cohrs S.; Einsiedel R.V.; Falkai P.; Großkopf V.; Hauth I.; Steiner J. Legal aspects of delegation and reorganisation of medical services in the psychiatric field; [Rechtliche Aspekte von Delegation und Neuorganisation ärztlicher Tätigkeiten im psychiatrischen Fachgebiet]. Psychiatrische Praxis. 2011;38(SUPPL. 2):S1–S7.

Gos T.; Bogerts B.; Steiner J. Neuronal activity patterns in depression assessed post mortem - Which impacts have suicidality and unipolar-bipolar dichotomy?; [Post-mortem-untersuchungen zu neuronalen aktivierungsmustern bei depressiven patienten - Welchen einfluss haben suizidalität und unipolar-bipolar-dichotomie?]. Nervenheilkunde. 2011;30(11):909–913.

Bernstein H.-G.; Keilhoff G.; Steiner J.; Dobrowolny H.; Bogerts B. Nitric oxide and schizophrenia: Present knowledge and emerging concepts of therapy. CNS and Neurological Disorders - Drug Targets. 2011;10(7):792–807.

Bernstein H.-G.; Lendeckel U.; Steiner J.; Bogerts B. Oestrogen downregulates BACE protein in human cell culture: What does this teach us about Alzheimer's disease?. Neurodegenerative Diseases. 2011;8(3):153–154.

Steiner J.; Sarnyai Z.; Westphal S.; Gos T.; Bernstein H.-G.; Bogerts B.; Keilhoff G. Protective effects of haloperidol and clozapine on energy-deprived OLN-93 oligodendrocytes. European Archives of Psychiatry and Clinical Neuroscience. 2011;261(7):477–482.

Schmitt A.; Schulenberg W.; Bernstein H.-G.; Steiner J.; Schneider-Axmann T.; Yeganeh-Doost P.; Malchow B.; Hasan A.; Gruber O.; Bogerts B.; Falkai P. Reduction of gyrification index in the cerebellar vermis in schizophrenia: A post-mortem study. World Journal of Biological Psychiatry. 2011;12(SUPPL. 1):99–103.

Steiner J.; Bogerts B.; Schroeter M.L.; Bernstein H.-G. S100B protein in neurodegenerative disorders. Clinical Chemistry and Laboratory Medicine. 2011;49(3):409–424.

Steiner J.; Walter M.; Gos T.; Guillemin G.J.; Bernstein H.-G.; Sarnyai Z.; Mawrin C.; Brisch R.; Bielau H.; zu Schwabedissen L.M.; Bogerts B.; Myint A.-M. Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?. Journal of Neuroinflammation. 2011;8:94.

Jordan W.; Adler L.; Bleich S.; Von Einsiedel R.; Falkai P.; Großkopf V.; Hauth I.; Steiner J.; Cohrs S. Shortage of doctors in psychiatric hospitals providing for the future by reorganizing medical services; [Ärztemangel im psychiatrischen Krankenhaus Zukunftssicherung durch Neuordnung des ärztlichen Dienstes: Eine Umsetzungsanalyse]. Psychiatrische Praxis. 2011;38(SUPPL. 2):S16–S24.

Steiner J.; Jacobs R.; Panteli B.; Brauner M.; Schiltz K.; Bahn S.; Herberth M.; Westphal S.; Gos T.; Walter M.; Bernstein H.-G.; Myint A.M.; Bogerts B. Acute schizophrenia is accompanied by reduced T cell and increased B cell immunity. European Archives of Psychiatry and Clinical Neuroscience. 2010;260(7):509–518.

Bernstein H.-G.; Müller S.; Steiner J.; Farkas N.; Bogerts B.; Lendeckel U. Association between paternal schizophrenia and low birthweight: ADAM12 may matter. Asian Journal of Andrology. 2010;12(3):453–454.

Gos T.; Krell D.; Bielau H.; Steiner J.; Mawrin C.; Trübner K.; Brisch R.; Bernstein H.-G.; Jankowski Z.; Bogerts B. Demonstration of disturbed activity of the lateral amygdaloid nucleus projection neurons in depressed patients by the AgNOR staining method. Journal of Affective Disorders. 2010;126(3):402–410.

Steiner J.; Walter M.; Guest P.; Myint A.M.; Schiltz K.; Panteli B.; Brauner M.; Bernstein H.-G.; Gos T.; Herberth M.; Schroeter M.L.; Schwarz M.J.; Westphal S.; Bahn S.; Bogerts B. Elevated S100B levels in schizophrenia are associated with insulin resistance. Molecular Psychiatry. 2010;15(1):3–4.

Horn D.I.; Yu C.; Steiner J.; Buchmann J.; Kaufmann J.; Osoba A.; Eckert U.; Zierhut K.C.; Schiltz K.; He H.; Biswa B.; Bogerts B.; Walter M. Glutamatergic and resting-state functional connectivity correlates of severity in major depression - the role of pregenual anterior cingulate cortex and anterior insula. Frontiers in Systems Neuroscience. 2010;4:33.

Steiner J.; Schroeter M.L.; Schiltz K.; Bernstein H.G.; Müller U.J.; Richter-Landsberg C.; Müller W.E.; Walter M.; Gos T.; Bogerts B.; Keilhoff G. Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience. 2010;167(4):1025–1031.

Metzger C.D.; Eckert U.; Steiner J.; Sartorius A.; Buchmann J.E.; Stadler J.; Tempelmann C.; Speck O.; Bogerts B.; Abler B.; Walter M. High field fMRI reveals thalamocortical integration of segregated cognitive and emotional processing in mediodorsal and intralaminar thalamic nuclei. Frontiers in Neuroanatomy. 2010;(NOV).

Guest P.C.; Wang L.; Harris L.W.; Burling K.; Levin Y.; Ernst A.; Wayland M.T.; Umrania Y.; Herberth M.; Koethe D.; Van Beveren J.M.; Rothermundt M.; McAllister G.; Leweke F.M.; Steiner J.; Bahn S. Increased levels of circulating insulin-related peptides in first-onset, antipsychotic nave schizophrenia patients. Molecular Psychiatry. 2010;15(2):118–119.

Dürrschmidt D.; Smalla K.-H.; Kreutz M.R.; Dobrowolny H.; Steiner J.; Keilhoff G.; Bogerts B.; Bernstein H.-G. Increased oligodendroglial expression of the cell proliferation?controlling protein prohibitin in schizophrenia. A hint for cell cycle abnormalities?. Acta Clinica Croatica. 2010;49(SUPPL. 2):39–41.

Kirches E.; Steiner J.; Schneider T.; Vorwerk C.K.; Scherlach C.; Holtkamp N.; Keilhoff G.; Eng C.; Mawrin C. Lhermitte-Duclos disease caused by a novel germline PTEN mutation R173P in a patient presenting with psychosis: Scientific correspondence. Neuropathology and Applied Neurobiology. 2010;36(1):86–89.

Schroeter M.L.; Abdul-Khaliq H.; Sacher J.; Steiner J.; Blasig I.E.; Mueller K. Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology. 2010;:780645.

Farkas N.; Lendeckel U.; Dobrowolny H.; Funke S.; Steiner J.; Keilhoff G.; Schmitt A.; Bogerts B.; Bernstein H.-G. Reduced density of ADAM 12-immunoreactive oligodendrocytes in the anterior cingulate white matter of patients with schizophrenia. World Journal of Biological Psychiatry. 2010;11(3):556–566.

Steiner J.; Schiltz K.; Walter M.; Wunderlich M.T.; Keilhoff G.; Brisch R.; Bielau H.; Bernstein H.-G.; Bogerts B.; Schroeter M.L.; Westphal S. S100B serum levels are closely correlated with body mass index: An important caveat in neuropsychiatric research. Psychoneuroendocrinology. 2010;35(2):321–324.

Steiner J.; Myint A.M.; Schiltz K.; Westphal S.; Bernstein H.-G.; Walter M.; Schroeter M.L.; Schwarz M.J.; Bogerts B. S100B serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovascular Psychiatry and Neurology. 2010;:480707.

Bernstein H.-G.; Heinemann A.; Steiner J.; Bogerts B. Schizophrenia, sleep disturbances and the suprachiasmatic nucleus: Reduced nitric oxide synthase may matter. Medical Hypotheses. 2010;74(2):397–398.

Zierhut K.; Bogerts B.; Schott B.; Fenker D.; Walter M.; Albrecht D.; Steiner J.; Schütze H.; Northoff G.; Düzel E.; Schiltz K. The role of hippocampus dysfunction in deficient memory encoding and positive symptoms in schizophrenia. Psychiatry Research - Neuroimaging. 2010;183(3):187–194.

Schwarz E.; Izmailov R.; Spain M.; Barnes A.; Mapes J.P.; Guest P.C.; Rahmoune H.; Pietsch S.; Markus Leweke F.; Rothermundt M.; Steiner J.; Koethe D.; Kranaster L.; Ohrmann P.; Suslow T.; Levin Y.; Bogerts B.; van Beveren N.; McAllister G.; Weber N.; Niebuhr D.; Cowan D.; Yolken R.H.; Bahn S. Validation of a blood-based laboratory test to aid in the confirmation of a diagnosis of schizophrenia. Biomarker Insights. 2010;2010(5):39–47.

Bernstein H.-G.; Ernst T.S.; Lendeckel U.; Dobrowolny H.; Steiner J.; Bogerts B. What protects patients with schizophrenia from developing alzheimer pathology?. Brain Protection in Schizophrenia, Mood and Cognitive Disorders. 2010;:45–66.

Steiner J.; Walter M.; Wunderlich M.T.; Bernstein H.-G.; Panteli B.; Brauner M.; Jacobs R.; Gos T.; Rothermundt M.; Bogerts B. A New Pathophysiological Aspect of S100B in Schizophrenia: Potential Regulation of S100B by Its Scavenger Soluble RAGE. Biological Psychiatry. 2009;65(12):1107–1110.

Bogerts B.; Steiner J.; Bernstein H.-G. Brain abnormalities in schizophrenia. Schizophrenia, Second Edition. 2009;:87–104.

Gos T.; Krell D.; Bielau H.; Steiner J.; Trübner K.; Brisch R.; Bernstein H.-G.; Jankowski Z.; Bogerts B. Demonstration of disturbed activity of external globus pallidus projecting neurons in depressed patients by the AgNOR staining method. Journal of Affective Disorders. 2009;119(1-3):149–155.

Gos T.; Krell D.; Bielau H.; Steiner J.; Mawrin C.; Trübner K.; Brisch R.; Bernstein H.-G.; Jankowski Z.; Bogerts B. Demonstration of disturbed activity of orbitofrontal pyramidal neurons in depressed patients by the AgNOR staining method. Journal of Affective Disorders. 2009;118(1-3):131–138.

Brisch R.; Bernstein H.-G.; Krell D.; Dobrowolny H.; Bielau H.; Steiner J.; Gos T.; Funke S.; Stauch R.; Knüppel S.; Bogerts B. Dopamine-glutamate abnormalities in the frontal cortex associated with the catechol-O-methyltransferase (COMT) in schizophrenia. Brain Research. 2009;1269:166–175.

Schroeter M.L.; Steiner J. Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Molecular Psychiatry. 2009;14(3):235–237.

Bernstein H.-G.; Steiner J.; Bogerts B. Glial cells in schizophrenia: Pathophysiological significance and possible consequences for therapy. Expert Review of Neurotherapeutics. 2009;9(7):1059–1071.

Bernstein H.-G.; Stricker R.; Lendeckel U.; Bertram I.; Dobrowolny H.; Steiner J.; Bogerts B.; Reiser G. Reduced neuronal co-localisation of nardilysin and the putative α-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains. Age. 2009;31(1):11–25.

Bernstein H.-G.; Ernst T.; Lendeckel U.; Bukowska A.; Ansorge S.; Stauch R.; Have S.T.; Steiner J.; Dobrowolny H.; Bogerts B. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia. Journal of Psychiatric Research. 2009;43(13):1095–1105.

Gos T.; Günther K.; Bielau H.; Dobrowolny H.; Mawrin C.; Trübner K.; Brisch R.; Steiner J.; Bernstein H.-G.; Jankowski Z.; Bogerts B. Suicide and depression in the quantitative analysis of glutamic acid decarboxylase-Immunoreactive neuropil. Journal of Affective Disorders. 2009;113(1-2):45–55.

Bernstein H.-G.; Lendeckel U.; Dobrowolny H.; Stauch R.; Steiner J.; Grecksch G.; Becker A.; Jirikowski G.F.; Bogerts B. Beacon-like/ubiquitin-5-like immunoreactivity is highly expressed in human hypothalamus and increased in haloperidol-treated schizophrenics and a rat model of schizophrenia. Psychoneuroendocrinology. 2008;33(3):340–351.

Gos T.; Krell D.; Brisch R.; Bielau H.; Trübner K.; Steiner J.; Bernstein H.-G.; Bogerts B. Demonstration of decreased activity of dorsal raphe nucleus neurons in depressed suicidal patients by the AgNOR staining method. Journal of Affective Disorders. 2008;111(2-3):251–260.

Steiner J.; Bielau H.; Brisch R.; Danos P.; Ullrich O.; Mawrin C.; Bernstein H.-G.; Bogerts B. Immunological aspects in the neurobiology of suicide: Elevated microglial density in schizophrenia and depression is associated with suicide. Journal of Psychiatric Research. 2008;42(2):151–157.

Bernstein H.-G.; Lendeckel U.; Bukowska A.; Ansorge S.; Ernst T.; Stauch R.; Trübner K.; Steiner J.; Dobrowolny H.; Bogerts B. Regional and cellular distribution patterns of insulin-degrading enzyme in the adult human brain and pituitary. Journal of Chemical Neuroanatomy. 2008;35(2):216–224.

Steiner J.; Bernstein H.-G.; Bogerts B.; Gos T.; Richter-Landsberg C.; Wunderlich M.T.; Keilhoff G. S100B is expressed in, and released from, OLN-93 oligodendrocytes: Influence of serum and glucose deprivation. Neuroscience. 2008;154(2):496–503.

Steiner J.; Bernstein H.-G.; Bielau H.; Farkas N.; Winter J.; Dobrowolny H.; Brisch R.; Gos T.; Mawrin C.; Myint A.M.; Bogerts B. S100B-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: A morphometric study. Journal of Psychiatric Research. 2008;42(10):868–876.

Brisch R.; Bernstein H.-G.; Stauch R.; Dobrowolny H.; Krell D.; Truebner K.; Meyer-Lotz G.; Bielau H.; Steiner J.; Kropf S.; Gos T.; Danos P.; Bogerts B. The volumes of the fornix in schizophrenia and affective disorders: A post-mortem study. Psychiatry Research - Neuroimaging. 2008;164(3):265–273.

Gos T.; Krell D.; Bielau H.; Brisch R.; Trübner K.; Steiner J.; Bernstein H.-G.; Jankowski Z.; Bogerts B. Tyrosine hydroxylase immunoreactivity in the locus coeruleus is elevated in violent suicidal depressive patients. European Archives of Psychiatry and Clinical Neuroscience. 2008;258(8):513–520.

Steiner J.; Bogerts B.; Hoffmeyer D.; Brinkers M. Cenesthesia as a rare differential diagnosis of persistent idiopathic facial; [Zönästhesien als eine seltene differenzialdiagnose zum anhaltenden idiopathischen gesichtsschmerz]. Nervenarzt. 2007;78(2):198–201.

Bielau H.; Steiner J.; Mawrin C.; Trübner K.; Brisch R.; Meyer-Lotz G.; Brodhun M.; Dobrowolny H.; Baumann B.; Gos T.; Bernstein H.-G.; Bogerts B. Dysregulation of GABAergic neurotransmission in mood disorders: A postmortem study. Annals of the New York Academy of Sciences. 2007;1096:157–169.

Steiner J.; Bernstein H.-G.; Bielau H.; Berndt A.; Brisch R.; Mawrin C.; Keilhoff G.; Bogerts B. Evidence for a wide extra-astrocytic distribution of S100B in human brain. BMC Neuroscience. 2007;8:2.

Steiner J.; Zajontz H.; Reiss S.; Bogerts B. Differential diagnosis of anorexia nervosa and depression. A case report of Addison's disease in a female patient; [Differenzialdiagnose der anorexia nervosa und der depression: Fallbeispiel einer patientin mit morbus Addison]. Nervenarzt. 2006;77(3):338–342.

Steiner J.; Mawrin C.; Ziegeler A.; Bielau H.; Ullrich O.; Bernstein H.-G.; Bogerts B. Distribution of HLA-DR-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathologica. 2006;112(3):305–316.

Steiner J.; Bielau H.; Bernstein H.-G.; Bogerts B.; Wunderlich M.T. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones. Journal of Neurology, Neurosurgery and Psychiatry. 2006;77(11):1284–1287.

Steiner J.; Schiltz K.; Heidenreich F.; Weissenborn K. Dercum's disease - An often overlooked disease entity; [Lipomatosis dolorosa - Ein häufig übersehenes krankheitsbild]. Nervenarzt. 2002;73(2):183–187.